EA029272B1 - Пуриновые производные, применимые в качестве ингибиторов hsp90 - Google Patents
Пуриновые производные, применимые в качестве ингибиторов hsp90 Download PDFInfo
- Publication number
- EA029272B1 EA029272B1 EA201270535A EA201270535A EA029272B1 EA 029272 B1 EA029272 B1 EA 029272B1 EA 201270535 A EA201270535 A EA 201270535A EA 201270535 A EA201270535 A EA 201270535A EA 029272 B1 EA029272 B1 EA 029272B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- propyl
- ethyl
- isopropylamino
- methyl
- dioxol
- Prior art date
Links
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title abstract description 3
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title abstract 2
- 239000003481 heat shock protein 90 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 208
- 238000011282 treatment Methods 0.000 claims abstract description 9
- -1 3,3-dimethyl-but-1-ynyl Chemical group 0.000 claims description 1803
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 523
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 418
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 361
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 319
- 229910052757 nitrogen Inorganic materials 0.000 claims description 230
- 125000005605 benzo group Chemical group 0.000 claims description 226
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 208
- 239000000460 chlorine Substances 0.000 claims description 126
- 238000000034 method Methods 0.000 claims description 123
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 93
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 93
- 125000003118 aryl group Chemical group 0.000 claims description 90
- 229960000643 adenine Drugs 0.000 claims description 73
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 72
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 63
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 claims description 60
- 125000000217 alkyl group Chemical group 0.000 claims description 58
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 56
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 49
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 47
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 44
- 229910052739 hydrogen Inorganic materials 0.000 claims description 38
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 36
- 239000001257 hydrogen Substances 0.000 claims description 36
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 34
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 33
- 125000000304 alkynyl group Chemical group 0.000 claims description 33
- 229910052736 halogen Inorganic materials 0.000 claims description 33
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 31
- 239000001294 propane Substances 0.000 claims description 31
- 150000002367 halogens Chemical class 0.000 claims description 30
- 125000006316 iso-butyl amino group Chemical group [H]N(*)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 29
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 28
- 229910052760 oxygen Inorganic materials 0.000 claims description 26
- 229910052799 carbon Inorganic materials 0.000 claims description 25
- 125000004122 cyclic group Chemical group 0.000 claims description 24
- 125000005842 heteroatom Chemical group 0.000 claims description 22
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 21
- 229910052717 sulfur Inorganic materials 0.000 claims description 21
- 239000001301 oxygen Substances 0.000 claims description 20
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 20
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 19
- 239000011593 sulfur Substances 0.000 claims description 19
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 17
- 229930192474 thiophene Natural products 0.000 claims description 17
- 125000001424 substituent group Chemical group 0.000 claims description 16
- 206010028980 Neoplasm Diseases 0.000 claims description 14
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 claims description 13
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 claims description 12
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 12
- 125000006308 propyl amino group Chemical group 0.000 claims description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 10
- 125000005843 halogen group Chemical group 0.000 claims description 10
- 125000003342 alkenyl group Chemical group 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims description 8
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 7
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 6
- 201000011510 cancer Diseases 0.000 claims description 6
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 claims description 6
- 230000004770 neurodegeneration Effects 0.000 claims description 6
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 6
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 claims description 5
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 5
- 229930024421 Adenine Natural products 0.000 claims description 5
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 claims description 4
- CLGUKFNQTOCQDG-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[[6-(1h-pyrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCNCC(C)C)C=1CC1=CC=2OCCOC=2C=C1C=1C=CNN=1 CLGUKFNQTOCQDG-UHFFFAOYSA-N 0.000 claims description 3
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 3
- RWDCITLWLGCCJT-UHFFFAOYSA-N 8-(3-iodonaphthalen-2-yl)sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC4=CC=CC=C4C=3)I)=NC2=C1N RWDCITLWLGCCJT-UHFFFAOYSA-N 0.000 claims description 3
- 229920000305 Nylon 6,10 Polymers 0.000 claims description 3
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 claims description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 3
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- HDFWKQKSLRXFFF-UHFFFAOYSA-N 8-[[6-(2-phenylethynyl)-1,3-benzodioxol-5-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2OCOC=2C=C1C#CC1=CC=CC=C1 HDFWKQKSLRXFFF-UHFFFAOYSA-N 0.000 claims description 2
- QGWBWRZAEAMZCO-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-(5-methoxy-2-thiophen-2-ylphenyl)sulfanylpurin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)(C)C)C=1SC1=CC(OC)=CC=C1C1=CC=CS1 QGWBWRZAEAMZCO-UHFFFAOYSA-N 0.000 claims description 2
- JCHVHNXVRNVJSL-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[(5-thiophen-2-yl-2,3-dihydro-1-benzofuran-6-yl)sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)(C)C)C=1SC1=CC=2OCCC=2C=C1C1=CC=CS1 JCHVHNXVRNVJSL-UHFFFAOYSA-N 0.000 claims description 2
- GNZBBBFEWKVWLU-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[2-(furan-2-yl)-5-methoxyphenyl]sulfanylpurin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)(C)C)C=1SC1=CC(OC)=CC=C1C1=CC=CO1 GNZBBBFEWKVWLU-UHFFFAOYSA-N 0.000 claims description 2
- LQCCHYJASZQDSG-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[5-methoxy-2-(1h-pyrazol-5-yl)phenyl]sulfanylpurin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)(C)C)C=1SC1=CC(OC)=CC=C1C=1C=CNN=1 LQCCHYJASZQDSG-UHFFFAOYSA-N 0.000 claims description 2
- VSLGCTHNSARJOW-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[[5-(furan-2-yl)-2,3-dihydro-1-benzofuran-6-yl]sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)(C)C)C=1SC1=CC=2OCCC=2C=C1C1=CC=CO1 VSLGCTHNSARJOW-UHFFFAOYSA-N 0.000 claims description 2
- ROASJEHPZNKHOF-UHFFFAOYSA-N hexyl carbamate Chemical compound CCCCCCOC(N)=O ROASJEHPZNKHOF-UHFFFAOYSA-N 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000006708 (C5-C14) heteroaryl group Chemical group 0.000 claims 6
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 5
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims 5
- 125000006717 (C3-C10) cycloalkenyl group Chemical group 0.000 claims 4
- 125000000656 azaniumyl group Chemical group [H][N+]([H])([H])[*] 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 2
- ZFMJTBHCAGPOJA-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[(6-ethynyl-2,3-dihydro-1h-inden-5-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)(C)C)C(SC=3C(=CC=4CCCC=4C=3)C#C)=NC2=C1N ZFMJTBHCAGPOJA-UHFFFAOYSA-N 0.000 claims 2
- NJNKSCQLKJFJDP-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-(2-ethynyl-5-methoxyphenyl)sulfanylpurin-6-amine Chemical compound COC1=CC=C(C#C)C(SC=2N(C3=NC=NC(N)=C3N=2)CCNCC(C)(C)C)=C1 NJNKSCQLKJFJDP-UHFFFAOYSA-N 0.000 claims 1
- PNBOZZKLKLNHBS-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[(5-ethynyl-2,3-dihydro-1-benzofuran-6-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)(C)C)C(SC=3C(=CC=4CCOC=4C=3)C#C)=NC2=C1N PNBOZZKLKLNHBS-UHFFFAOYSA-N 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 101710113864 Heat shock protein 90 Proteins 0.000 abstract 1
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 187
- 239000011541 reaction mixture Substances 0.000 description 178
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 159
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 125
- 230000002829 reductive effect Effects 0.000 description 97
- 239000000203 mixture Substances 0.000 description 76
- 239000002904 solvent Substances 0.000 description 76
- 238000012746 preparative thin layer chromatography Methods 0.000 description 73
- 229910052740 iodine Inorganic materials 0.000 description 72
- 125000006309 butyl amino group Chemical group 0.000 description 68
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 62
- 239000000243 solution Substances 0.000 description 62
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 59
- 238000004128 high performance liquid chromatography Methods 0.000 description 58
- 239000007787 solid Substances 0.000 description 58
- 102100037580 Sesquipedalian-1 Human genes 0.000 description 49
- 101710169844 Sesquipedalian-1 Proteins 0.000 description 49
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 45
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 40
- ZENKESXKWBIZCV-UHFFFAOYSA-N 2,2,4,4-tetrafluoro-1,3-benzodioxin-6-amine Chemical group O1C(F)(F)OC(F)(F)C2=CC(N)=CC=C21 ZENKESXKWBIZCV-UHFFFAOYSA-N 0.000 description 35
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 31
- 238000003818 flash chromatography Methods 0.000 description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- 125000004103 aminoalkyl group Chemical group 0.000 description 29
- 210000004556 brain Anatomy 0.000 description 29
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 28
- 125000003710 aryl alkyl group Chemical group 0.000 description 28
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 28
- 239000013592 cell lysate Substances 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 25
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 25
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 22
- 239000003153 chemical reaction reagent Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 19
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 18
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 18
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 18
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 18
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 17
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 15
- BHVOFCPOXNYVCE-UHFFFAOYSA-N 6-amino-7,9-dihydropurine-8-thione Chemical compound NC1=NC=NC2=C1NC(=S)N2 BHVOFCPOXNYVCE-UHFFFAOYSA-N 0.000 description 15
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 210000004958 brain cell Anatomy 0.000 description 14
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 14
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 14
- FEWLNYSYJNLUOO-UHFFFAOYSA-N 1-Piperidinecarboxaldehyde Chemical compound O=CN1CCCCC1 FEWLNYSYJNLUOO-UHFFFAOYSA-N 0.000 description 13
- 238000004587 chromatography analysis Methods 0.000 description 13
- 101150072179 ATP1 gene Proteins 0.000 description 12
- 101100003366 Arabidopsis thaliana ATPA gene Proteins 0.000 description 12
- 102100021649 Elongator complex protein 6 Human genes 0.000 description 12
- 101100065219 Homo sapiens ELP6 gene Proteins 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 125000003277 amino group Chemical group 0.000 description 12
- 101150105046 atpI gene Proteins 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 11
- 125000000623 heterocyclic group Chemical group 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- 239000011737 fluorine Substances 0.000 description 10
- 229910052731 fluorine Inorganic materials 0.000 description 10
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 10
- 239000012044 organic layer Substances 0.000 description 10
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 10
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 9
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 125000004093 cyano group Chemical group *C#N 0.000 description 9
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 9
- ALBYIUDWACNRRB-UHFFFAOYSA-N hexanamide Chemical compound CCCCCC(N)=O ALBYIUDWACNRRB-UHFFFAOYSA-N 0.000 description 9
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 8
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 8
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 8
- 101100293693 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) STO1 gene Proteins 0.000 description 8
- 125000004429 atom Chemical group 0.000 description 8
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 description 8
- 101150050497 cbc1 gene Proteins 0.000 description 8
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 8
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- XDIAMRVROCPPBK-UHFFFAOYSA-N 2,2-dimethylpropan-1-amine Chemical compound CC(C)(C)CN XDIAMRVROCPPBK-UHFFFAOYSA-N 0.000 description 7
- BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 7
- 101150116038 AEP2 gene Proteins 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 125000003282 alkyl amino group Chemical group 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 125000001309 chloro group Chemical group Cl* 0.000 description 7
- 125000001153 fluoro group Chemical group F* 0.000 description 7
- PZJSZBJLOWMDRG-UHFFFAOYSA-N furan-2-ylboronic acid Chemical compound OB(O)C1=CC=CO1 PZJSZBJLOWMDRG-UHFFFAOYSA-N 0.000 description 7
- 239000011630 iodine Substances 0.000 description 7
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 7
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 7
- IYRGXJIJGHOCFS-UHFFFAOYSA-N neocuproine Chemical compound C1=C(C)N=C2C3=NC(C)=CC=C3C=CC2=C1 IYRGXJIJGHOCFS-UHFFFAOYSA-N 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- NEUWPDLMDVINSN-UHFFFAOYSA-N 1h-pyrazol-5-ylboronic acid Chemical compound OB(O)C=1C=CNN=1 NEUWPDLMDVINSN-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- 206010006187 Breast cancer Diseases 0.000 description 6
- 208000026310 Breast neoplasm Diseases 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229940124530 sulfonamide Drugs 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 125000004966 cyanoalkyl group Chemical group 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 5
- LXCICYRNWIGDQA-UHFFFAOYSA-N 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2-oxazole Chemical compound O1C(C)(C)C(C)(C)OB1C1=CON=C1 LXCICYRNWIGDQA-UHFFFAOYSA-N 0.000 description 4
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 4
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 4
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 4
- 101100037618 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ant-1 gene Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 4
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 4
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 4
- 150000002460 imidazoles Chemical class 0.000 description 4
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- GGIUUCJLIYQRAE-UHFFFAOYSA-N propyl sulfamate Chemical compound CCCOS(N)(=O)=O GGIUUCJLIYQRAE-UHFFFAOYSA-N 0.000 description 4
- 150000003222 pyridines Chemical class 0.000 description 4
- PZRKPUQWIFJRKZ-UHFFFAOYSA-N pyrimidine-2,4,5,6-tetramine Chemical compound NC1=NC(N)=C(N)C(N)=N1 PZRKPUQWIFJRKZ-UHFFFAOYSA-N 0.000 description 4
- ARYHTUPFQTUBBG-UHFFFAOYSA-N thiophen-2-ylboronic acid Chemical compound OB(O)C1=CC=CS1 ARYHTUPFQTUBBG-UHFFFAOYSA-N 0.000 description 4
- IKDMREAHMCMBIG-UHFFFAOYSA-N 1,3-dioxole-4-carbonitrile Chemical compound N#CC1=COCO1 IKDMREAHMCMBIG-UHFFFAOYSA-N 0.000 description 3
- FNPZFZKLYGWKLH-UHFFFAOYSA-N 4,4,5,5-tetramethyl-2-(5-methylfuran-2-yl)-1,3,2-dioxaborolane Chemical compound O1C(C)=CC=C1B1OC(C)(C)C(C)(C)O1 FNPZFZKLYGWKLH-UHFFFAOYSA-N 0.000 description 3
- MBLGEUGNABDCDM-UHFFFAOYSA-N 8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)sulfanyl]-7h-purin-6-amine Chemical compound N=1C=2C(N)=NC=NC=2NC=1SC(C(=C1)I)=CC2=C1CCO2 MBLGEUGNABDCDM-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 101100456282 Caenorhabditis elegans mcm-4 gene Proteins 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101000587820 Homo sapiens Selenide, water dikinase 1 Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102100031163 Selenide, water dikinase 1 Human genes 0.000 description 3
- JTFQDOHHXGSMFC-UHFFFAOYSA-N [1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrol-3-yl]boronic acid Chemical compound CC(C)(C)OC(=O)N1C=CC(B(O)O)=C1 JTFQDOHHXGSMFC-UHFFFAOYSA-N 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 125000004266 aziridin-1-yl group Chemical group [H]C1([H])N(*)C1([H])[H] 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 125000004663 dialkyl amino group Chemical group 0.000 description 3
- CYEFKCRAAGLNHW-UHFFFAOYSA-N furan-3-ylboronic acid Chemical compound OB(O)C=1C=COC=1 CYEFKCRAAGLNHW-UHFFFAOYSA-N 0.000 description 3
- 125000001072 heteroaryl group Chemical group 0.000 description 3
- 125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000003456 sulfonamides Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 3
- MGNBKNBEZGLHNF-UHFFFAOYSA-N (2-methylpyrazol-3-yl)boronic acid Chemical compound CN1N=CC=C1B(O)O MGNBKNBEZGLHNF-UHFFFAOYSA-N 0.000 description 2
- JUWYQISLQJRRNT-UHFFFAOYSA-N (5-formylfuran-2-yl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)O1 JUWYQISLQJRRNT-UHFFFAOYSA-N 0.000 description 2
- KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical group C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 description 2
- ZDLCRJZSWKJVQO-UHFFFAOYSA-N 2,3-dihydro-1-benzofuran-6-amine Chemical compound NC1=CC=C2CCOC2=C1 ZDLCRJZSWKJVQO-UHFFFAOYSA-N 0.000 description 2
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 2
- GPWNWKWQOLEVEQ-UHFFFAOYSA-N 2,4-diaminopyrimidine-5-carbaldehyde Chemical compound NC1=NC=C(C=O)C(N)=N1 GPWNWKWQOLEVEQ-UHFFFAOYSA-N 0.000 description 2
- VQKFNUFAXTZWDK-UHFFFAOYSA-N 2-Methylfuran Chemical compound CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 2
- INQUEXIWISVGOP-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCNCC(C)C)C=NC2=C1N INQUEXIWISVGOP-UHFFFAOYSA-N 0.000 description 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 2
- SSZKGJHMQYVGOZ-UHFFFAOYSA-N 8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCCC=4C=3)I)=NC2=C1N SSZKGJHMQYVGOZ-UHFFFAOYSA-N 0.000 description 2
- LHLCREWLMOTZJB-UHFFFAOYSA-N 8-[[7-(dimethylamino)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound CN(C)c1cc2OCCOc2cc1Sc1nc2c(N)ncnc2n1CCC1CCCN(C1)S(C)(=O)=O LHLCREWLMOTZJB-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 101100021265 Caenorhabditis elegans lin-5 gene Proteins 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 108010061414 Hepatocyte Nuclear Factor 1-beta Proteins 0.000 description 2
- 102100022123 Hepatocyte nuclear factor 1-beta Human genes 0.000 description 2
- 101000701815 Homo sapiens Spermidine synthase Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 102100029469 WD repeat and HMG-box DNA-binding protein 1 Human genes 0.000 description 2
- 101710097421 WD repeat and HMG-box DNA-binding protein 1 Proteins 0.000 description 2
- IUEPVMMFUSDDBJ-UHFFFAOYSA-N [1-[(2-methylpropan-2-yl)oxycarbonyl]pyrazol-4-yl]boronic acid Chemical compound CC(C)(C)OC(=O)N1C=C(B(O)O)C=N1 IUEPVMMFUSDDBJ-UHFFFAOYSA-N 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000037029 cross reaction Effects 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004896 high resolution mass spectrometry Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 2
- FLKRMXAWABTWSH-UHFFFAOYSA-N piperidine-1-sulfonamide Chemical compound NS(=O)(=O)N1CCCCC1 FLKRMXAWABTWSH-UHFFFAOYSA-N 0.000 description 2
- 229960005235 piperonyl butoxide Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- QGKLPGKXAVVPOJ-UHFFFAOYSA-N pyrrolidin-3-one Chemical compound O=C1CCNC1 QGKLPGKXAVVPOJ-UHFFFAOYSA-N 0.000 description 2
- FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 101150011513 yrrT gene Proteins 0.000 description 2
- QBLFZIBJXUQVRF-UHFFFAOYSA-N (4-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Br)C=C1 QBLFZIBJXUQVRF-UHFFFAOYSA-N 0.000 description 1
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 description 1
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 1
- MNJYZNVROSZZQC-UHFFFAOYSA-N (4-tert-butylphenyl)boronic acid Chemical compound CC(C)(C)C1=CC=C(B(O)O)C=C1 MNJYZNVROSZZQC-UHFFFAOYSA-N 0.000 description 1
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
- JNVXRQOSRUDXDY-UHFFFAOYSA-N 1,1-diiodoethane Chemical compound CC(I)I JNVXRQOSRUDXDY-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
- RQMXOMCWRSEQQC-UHFFFAOYSA-N 1,4-dioxine-2-carbonitrile Chemical compound N#CC1=COC=CO1 RQMXOMCWRSEQQC-UHFFFAOYSA-N 0.000 description 1
- HGVWMTAIIYNQSI-UHFFFAOYSA-N 1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone Chemical compound O1CCOC2=CC(C(=O)C)=CC=C21 HGVWMTAIIYNQSI-UHFFFAOYSA-N 0.000 description 1
- LKRJUEMIWFNXLK-UHFFFAOYSA-N 1-[3-[2-[6-amino-2-fluoro-8-[[6-(1h-pyrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound C1N(C(=O)C)CCCC1CCN1C2=NC(F)=NC(N)=C2N=C1CC(C(=C1)C=2NN=CC=2)=CC2=C1OCCO2 LKRJUEMIWFNXLK-UHFFFAOYSA-N 0.000 description 1
- UPIHLCUPAUYKDO-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[(7-ethynyl-2,3-dihydro-1,4-benzodioxin-6-yl)sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound C1N(C(=O)C)CCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C#C)=CC2=C1OCCO2 UPIHLCUPAUYKDO-UHFFFAOYSA-N 0.000 description 1
- OHRKTDQHSGQTIR-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[[3-(1,3-oxazol-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound CC(=O)N1CCCC(CCn2c(Sc3cc4CCCCc4cc3-c3ncco3)nc3c(N)ncnc23)C1 OHRKTDQHSGQTIR-UHFFFAOYSA-N 0.000 description 1
- MQGYRZIAJUUYMJ-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[[3-(1H-pyrazol-5-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound CC(=O)N1CCCC(CCn2c(Sc3cc4CCCCc4cc3-c3cc[nH]n3)nc3c(N)ncnc23)C1 MQGYRZIAJUUYMJ-UHFFFAOYSA-N 0.000 description 1
- OSPPUUGTEUJERA-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[[3-(5-methylfuran-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound C1N(C(=O)C)CCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C=2OC(C)=CC=2)=CC2=C1CCCC2 OSPPUUGTEUJERA-UHFFFAOYSA-N 0.000 description 1
- LEQRHKWPGZQONF-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[[6-(1,3-oxazol-2-yl)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound C1N(C(=O)C)CCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C=2OC=CN=2)=CC2=C1OCC2 LEQRHKWPGZQONF-UHFFFAOYSA-N 0.000 description 1
- NUDTYZDZJYLDSD-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[[6-(1H-pyrazol-5-yl)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound CC(=O)N1CCCC(CCn2c(Sc3cc4CCOc4cc3-c3cc[nH]n3)nc3c(N)ncnc23)C1 NUDTYZDZJYLDSD-UHFFFAOYSA-N 0.000 description 1
- FWDCBLRZKPKBGC-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1h-inden-5-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound C1N(C(=O)C)CCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C=2OC(C)=CN=2)=CC2=C1CCC2 FWDCBLRZKPKBGC-UHFFFAOYSA-N 0.000 description 1
- RERKCAPAZUTYPT-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[[7-(5-methylfuran-2-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound NC1=C2N=C(N(C2=NC=N1)CCC1CN(CCC1)C(C)=O)SC1=CC2=C(OCCO2)C=C1C=1OC(=CC1)C RERKCAPAZUTYPT-UHFFFAOYSA-N 0.000 description 1
- KPODTUBWSZCXIG-UHFFFAOYSA-N 1-[3-[2-[6-amino-8-[[7-(ethylamino)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound CCNC1=CC=2OCCOC=2C=C1SC1=NC2=C(N)N=CN=C2N1CCC1CCCN(C(C)=O)C1 KPODTUBWSZCXIG-UHFFFAOYSA-N 0.000 description 1
- KSBNFTJNMCNANC-UHFFFAOYSA-N 1-[3-[6-amino-8-[(3-iodo-5,6,7,8-tetrahydronaphthalen-2-yl)sulfanyl]purin-9-yl]propyl]pyrrolidin-3-one Chemical compound C=1C=2CCCCC=2C=C(I)C=1SC1=NC=2C(N)=NC=NC=2N1CCCN1CCC(=O)C1 KSBNFTJNMCNANC-UHFFFAOYSA-N 0.000 description 1
- KHPOMEQGYGEBAP-UHFFFAOYSA-N 1-[3-[6-amino-8-[[6-(4-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1h-inden-5-yl]sulfanyl]purin-9-yl]propyl]pyrrolidin-3-one Chemical compound CC1=COC(C=2C(=CC=3CCCC=3C=2)SC=2N(C3=NC=NC(N)=C3N=2)CCCN2CC(=O)CC2)=N1 KHPOMEQGYGEBAP-UHFFFAOYSA-N 0.000 description 1
- UPZAPHPORZUWBA-UHFFFAOYSA-N 1-[4-[2-[6-amino-2-chloro-8-[[6-(furan-2-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound CC(=O)N1CCC(CCn2c(Cc3cc4OCCOc4cc3-c3ccco3)nc3c(N)nc(Cl)nc23)CC1 UPZAPHPORZUWBA-UHFFFAOYSA-N 0.000 description 1
- ROLYDQLYIMJAIV-UHFFFAOYSA-N 1-[4-[2-[6-amino-2-fluoro-8-[[5-methoxy-2-(5-methylfuran-2-yl)phenyl]methyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound COc1ccc(-c2ccc(C)o2)c(Cc2nc3c(N)nc(F)nc3n2CCC2CCN(CC2)C(C)=O)c1 ROLYDQLYIMJAIV-UHFFFAOYSA-N 0.000 description 1
- ZXYKUJUXTUBDLC-UHFFFAOYSA-N 1-[4-[2-[6-amino-2-fluoro-8-[[6-(1h-pyrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1CCN1C2=NC(F)=NC(N)=C2N=C1CC(C(=C1)C=2NN=CC=2)=CC2=C1OCCO2 ZXYKUJUXTUBDLC-UHFFFAOYSA-N 0.000 description 1
- BXWDDFYSANBWLH-UHFFFAOYSA-N 1-[4-[2-[6-amino-8-[(6-cyclopropyl-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]-2-fluoropurin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1CCN1C2=NC(F)=NC(N)=C2N=C1CC(C(=C1)C2CC2)=CC2=C1OCCO2 BXWDDFYSANBWLH-UHFFFAOYSA-N 0.000 description 1
- VKPJGMJPUDDXOX-UHFFFAOYSA-N 1-[4-[2-[6-amino-8-[(7-cyclopropyl-2,3-dihydro-1,4-benzodioxin-6-yl)sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound NC1=C2N=C(N(C2=NC=N1)CCC1CCN(CC1)C(C)=O)SC1=CC2=C(OCCO2)C=C1C1CC1 VKPJGMJPUDDXOX-UHFFFAOYSA-N 0.000 description 1
- DVPUQNJCKNMDNU-UHFFFAOYSA-N 1-[4-[2-[6-amino-8-[2-[5-(aminomethyl)furan-2-yl]-5-methoxyphenyl]sulfanylpurin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound COc1ccc(-c2ccc(CN)o2)c(Sc2nc3c(N)ncnc3n2CCC2CCN(CC2)C(C)=O)c1 DVPUQNJCKNMDNU-UHFFFAOYSA-N 0.000 description 1
- PJTYPDPBEAVGGJ-UHFFFAOYSA-N 1-[4-[2-[6-amino-8-[[6-(dimethylamino)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound CN(C)C1=CC=2OCCC=2C=C1SC1=NC2=C(N)N=CN=C2N1CCC1CCN(C(C)=O)CC1 PJTYPDPBEAVGGJ-UHFFFAOYSA-N 0.000 description 1
- AWPRXHGVQFMZNI-UHFFFAOYSA-N 1-[4-[2-[6-amino-8-[[7-(5-methylfuran-2-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]ethanone Chemical compound CC(=O)N1CCC(CCn2c(Sc3cc4OCCOc4cc3-c3ccc(C)o3)nc3c(N)ncnc23)CC1 AWPRXHGVQFMZNI-UHFFFAOYSA-N 0.000 description 1
- DZXQJDGICODJAV-UHFFFAOYSA-N 1-[6-[6-amino-9-[3-(propan-2-ylamino)propyl]purin-8-yl]sulfanyl-5-iodo-2,3-dihydroindol-1-yl]ethanone Chemical compound CC(C)NCCCn1c(Sc2cc3N(CCc3cc2I)C(C)=O)nc2c(N)ncnc12 DZXQJDGICODJAV-UHFFFAOYSA-N 0.000 description 1
- NCZYUYLAYVMACN-UHFFFAOYSA-N 1-[6-amino-8-(2-ethynyl-5-methoxyphenyl)sulfanylpurin-9-yl]-3-(propan-2-ylamino)propan-2-ol Chemical compound COC1=CC=C(C#C)C(SC=2N(C3=NC=NC(N)=C3N=2)CC(O)CNC(C)C)=C1 NCZYUYLAYVMACN-UHFFFAOYSA-N 0.000 description 1
- DROZQIGPUVFXQV-UHFFFAOYSA-N 1-[6-amino-8-(5-methoxy-2-thiophen-2-ylphenyl)sulfanylpurin-9-yl]-3-(propan-2-ylamino)propan-2-ol Chemical compound N=1C2=C(N)N=CN=C2N(CC(O)CNC(C)C)C=1SC1=CC(OC)=CC=C1C1=CC=CS1 DROZQIGPUVFXQV-UHFFFAOYSA-N 0.000 description 1
- QYCLREBFBJUMDT-UHFFFAOYSA-N 1-[6-amino-8-[(6-iodo-3,4-dihydro-2H-chromen-7-yl)sulfanyl]purin-9-yl]-3-(propan-2-ylamino)propan-2-ol Chemical compound CC(C)NCC(O)Cn1c(Sc2cc3OCCCc3cc2I)nc2c(N)ncnc12 QYCLREBFBJUMDT-UHFFFAOYSA-N 0.000 description 1
- SQAINHDHICKHLX-UHFFFAOYSA-N 1-naphthaldehyde Chemical compound C1=CC=C2C(C=O)=CC=CC2=C1 SQAINHDHICKHLX-UHFFFAOYSA-N 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- ZHKJHQBOAJQXQR-UHFFFAOYSA-N 1H-azirine Chemical compound N1C=C1 ZHKJHQBOAJQXQR-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 1
- BZKOZYWGZKRTIB-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxin-6-amine Chemical compound O1CCOC2=CC(N)=CC=C21 BZKOZYWGZKRTIB-UHFFFAOYSA-N 0.000 description 1
- LEWZOBYWGWKNCK-UHFFFAOYSA-N 2,3-dihydro-1h-inden-5-amine Chemical compound NC1=CC=C2CCCC2=C1 LEWZOBYWGWKNCK-UHFFFAOYSA-N 0.000 description 1
- MFZBSWSCIWCRKS-UHFFFAOYSA-N 2,9-dimethyl-1,10-phenanthroline;hydrate Chemical compound O.C1=C(C)N=C2C3=NC(C)=CC=C3C=CC2=C1 MFZBSWSCIWCRKS-UHFFFAOYSA-N 0.000 description 1
- SFVHZPMQGRFPMM-UHFFFAOYSA-N 2-(1-benzofuran-6-yl)acetic acid Chemical compound OC(=O)CC1=CC=C2C=COC2=C1 SFVHZPMQGRFPMM-UHFFFAOYSA-N 0.000 description 1
- BVRNERFWPQRVJB-UHFFFAOYSA-N 2-(2,3-dihydro-1,4-benzodioxin-6-yl)acetic acid Chemical compound O1CCOC2=CC(CC(=O)O)=CC=C21 BVRNERFWPQRVJB-UHFFFAOYSA-N 0.000 description 1
- HBAUAIPLAXNUIM-UHFFFAOYSA-N 2-(2,3-dihydro-1-benzofuran-6-yl)acetic acid Chemical compound OC(=O)CC1=CC=C2CCOC2=C1 HBAUAIPLAXNUIM-UHFFFAOYSA-N 0.000 description 1
- VLZVIIYRNMWPSN-UHFFFAOYSA-N 2-Amino-4-nitrophenol Chemical compound NC1=CC([N+]([O-])=O)=CC=C1O VLZVIIYRNMWPSN-UHFFFAOYSA-N 0.000 description 1
- GRSINHCNTVNOCS-UHFFFAOYSA-N 2-[2-(2-methylpropylamino)ethyl]-7H-purin-6-amine Chemical compound C(C(C)C)NCCC1=NC(=C2N=CNC2=N1)N GRSINHCNTVNOCS-UHFFFAOYSA-N 0.000 description 1
- SLTIXJAJFQEDCR-UHFFFAOYSA-N 2-[6-amino-9-[3-(propan-2-ylamino)propyl]purin-8-yl]sulfanyl-4-methoxybenzonitrile Chemical compound NC1=C2N=C(N(C2=NC=N1)CCCNC(C)C)SC1=C(C#N)C=CC(=C1)OC SLTIXJAJFQEDCR-UHFFFAOYSA-N 0.000 description 1
- BFYZIJFYOVRILS-UHFFFAOYSA-N 2-[[6-amino-2-fluoro-9-[3-(propan-2-ylamino)propyl]purin-8-yl]methyl]-4-methoxybenzonitrile Chemical compound NC1=C2N=C(N(C2=NC(=N1)F)CCCNC(C)C)CC1=C(C#N)C=CC(=C1)OC BFYZIJFYOVRILS-UHFFFAOYSA-N 0.000 description 1
- PKWNDMMUPCRIIY-UHFFFAOYSA-N 2-chloro-8-[(5-ethynyl-2,3-dihydro-1-benzofuran-6-yl)methyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(CCNCC(C)C)C(CC=3C(=CC=4CCOC=4C=3)C#C)=NC2=C1N PKWNDMMUPCRIIY-UHFFFAOYSA-N 0.000 description 1
- FTRMFEBGXXDTPT-UHFFFAOYSA-N 2-chloro-8-[(6-ethynyl-2,3-dihydro-1h-inden-5-yl)methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(CCCNC(C)C)C(CC=3C(=CC=4CCCC=4C=3)C#C)=NC2=C1N FTRMFEBGXXDTPT-UHFFFAOYSA-N 0.000 description 1
- XZXKBKPDQCCYGG-UHFFFAOYSA-N 2-chloro-8-[(6-iodo-2,3-dihydro-1h-indol-5-yl)methyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(CCNCC(C)C)C(CC=3C(=CC=4NCCC=4C=3)I)=NC2=C1N XZXKBKPDQCCYGG-UHFFFAOYSA-N 0.000 description 1
- MEESSRQRYLAUBS-UHFFFAOYSA-N 2-chloro-8-[[3-(furan-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound ClC1=NC(=C2N=C(N(C2=N1)CCCNC(C)C)CC1=CC=2CCCCC=2C=C1C=1OC=CC=1)N MEESSRQRYLAUBS-UHFFFAOYSA-N 0.000 description 1
- HPPOMIJIDVIMTQ-UHFFFAOYSA-N 2-chloro-8-[[5-(5-methylfuran-2-yl)-2,3-dihydro-1-benzofuran-6-yl]methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound CC(C)NCCCn1c(Cc2cc3OCCc3cc2-c2ccc(C)o2)nc2c(N)nc(Cl)nc12 HPPOMIJIDVIMTQ-UHFFFAOYSA-N 0.000 description 1
- LTKBZFAYPFBCCQ-UHFFFAOYSA-N 2-chloro-8-[[6-(furan-2-yl)-2,3-dihydro-1H-inden-5-yl]methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound ClC1=NC(=C2N=C(N(C2=N1)CCCNC(C)C)CC=1C=C2CCCC2=CC1C=1OC=CC1)N LTKBZFAYPFBCCQ-UHFFFAOYSA-N 0.000 description 1
- YDLRCBVDCGGSTC-UHFFFAOYSA-N 2-chloro-9-[2-(2-methylpropylamino)ethyl]-8-[(6-pyrrolidin-1-yl-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(Cl)N=C2N(CCNCC(C)C)C=1CC1=CC=2OCCOC=2C=C1N1CCCC1 YDLRCBVDCGGSTC-UHFFFAOYSA-N 0.000 description 1
- APTVTOQHTTZZOB-UHFFFAOYSA-N 2-fluoro-8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)methyl]-7h-purin-6-amine Chemical compound N=1C=2C(N)=NC(F)=NC=2NC=1CC(C(=C1)I)=CC2=C1CCO2 APTVTOQHTTZZOB-UHFFFAOYSA-N 0.000 description 1
- BCQCHTGXLYCEAP-UHFFFAOYSA-N 2-fluoro-8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)methyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCNCC(C)C)C(CC=3C(=CC=4CCOC=4C=3)I)=NC2=C1N BCQCHTGXLYCEAP-UHFFFAOYSA-N 0.000 description 1
- NDJSGZXZPFMUSO-UHFFFAOYSA-N 2-fluoro-8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCCNC(C)C)C(CC=3C(=CC=4CCOC=4C=3)I)=NC2=C1N NDJSGZXZPFMUSO-UHFFFAOYSA-N 0.000 description 1
- IMBUXATZJUIFLD-UHFFFAOYSA-N 2-fluoro-8-[(5-iodo-2,3-dihydro-1-benzothiophen-6-yl)methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCCNC(C)C)C(CC=3C(=CC=4CCSC=4C=3)I)=NC2=C1N IMBUXATZJUIFLD-UHFFFAOYSA-N 0.000 description 1
- KFNRYMVVPGSPMU-UHFFFAOYSA-N 2-fluoro-8-[(5-methoxy-2-thiophen-2-ylphenyl)methyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCNCC(C)C)C=1CC1=CC(OC)=CC=C1C1=CC=CS1 KFNRYMVVPGSPMU-UHFFFAOYSA-N 0.000 description 1
- HEOKCSNULQGUDC-UHFFFAOYSA-N 2-fluoro-8-[(6-iodo-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]-7h-purin-6-amine Chemical compound O1CCOC(C=C2I)=C1C=C2CC(N1)=NC2=C1N=C(F)N=C2N HEOKCSNULQGUDC-UHFFFAOYSA-N 0.000 description 1
- RKKNHSJUEDMOPU-UHFFFAOYSA-N 2-fluoro-8-[(6-iodo-2,3-dihydro-1-benzofuran-5-yl)methyl]-9-[2-(1-methylsulfonylpyrrolidin-3-yl)ethyl]purin-6-amine Chemical compound FC1=NC(=C2N=C(N(C2=N1)CCC1CN(CC1)S(=O)(=O)C)CC=1C(=CC2=C(CCO2)C1)I)N RKKNHSJUEDMOPU-UHFFFAOYSA-N 0.000 description 1
- FMRQQAUFTXAXOX-UHFFFAOYSA-N 2-fluoro-8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)methyl]-9-[2-(1-methylpiperidin-2-yl)ethyl]purin-6-amine Chemical compound CN1CCCCC1CCN1C2=NC(F)=NC(N)=C2N=C1CC(C(=C1)I)=CC2=C1CCC2 FMRQQAUFTXAXOX-UHFFFAOYSA-N 0.000 description 1
- SPQNBAJLFLRLJF-UHFFFAOYSA-N 2-fluoro-8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)methyl]-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound C1N(S(=O)(=O)C)CCCC1CCN1C2=NC(F)=NC(N)=C2N=C1CC(C(=C1)I)=CC2=C1CCC2 SPQNBAJLFLRLJF-UHFFFAOYSA-N 0.000 description 1
- LLYSOLHUCYZKNG-UHFFFAOYSA-N 2-fluoro-8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)methyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCNCC(C)C)C(CC=3C(=CC=4CCCC=4C=3)I)=NC2=C1N LLYSOLHUCYZKNG-UHFFFAOYSA-N 0.000 description 1
- RNQVDWGZNRPBJQ-UHFFFAOYSA-N 2-fluoro-8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCCNC(C)C)C(CC=3C(=CC=4CCCC=4C=3)I)=NC2=C1N RNQVDWGZNRPBJQ-UHFFFAOYSA-N 0.000 description 1
- UQGPUDCDLHWTHC-UHFFFAOYSA-N 2-fluoro-8-[[5-methoxy-2-(1,2-oxazol-4-yl)phenyl]methyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound COc1ccc(-c2cnoc2)c(Cc2nc3c(N)nc(F)nc3n2CCNCC(C)C)c1 UQGPUDCDLHWTHC-UHFFFAOYSA-N 0.000 description 1
- SXDAACNQLNMFEL-UHFFFAOYSA-N 2-fluoro-8-[[6-(1,3-oxazol-2-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCCNC(C)C)C=1CC1=CC=2OCCOC=2C=C1C1=NC=CO1 SXDAACNQLNMFEL-UHFFFAOYSA-N 0.000 description 1
- WIBRTKIPORDXSV-UHFFFAOYSA-N 2-fluoro-8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCCNC(C)C)C=1CC1=CC=2OCCOC=2C=C1C1=NC=C(C)O1 WIBRTKIPORDXSV-UHFFFAOYSA-N 0.000 description 1
- DJRAHOMUECSKSG-UHFFFAOYSA-N 2-fluoro-8-[[6-(5-methylfuran-2-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound CC(C)CNCCn1c(Cc2cc3OCCOc3cc2-c2ccc(C)o2)nc2c(N)nc(F)nc12 DJRAHOMUECSKSG-UHFFFAOYSA-N 0.000 description 1
- OOKRPTWEQVSCDE-UHFFFAOYSA-N 2-fluoro-8-[[6-(furan-2-yl)-1-benzothiophen-5-yl]methyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound FC1=NC(=C2N=C(N(C2=N1)CCCNC(C)C)CC1=CC2=C(SC=C2)C=C1C=1OC=CC1)N OOKRPTWEQVSCDE-UHFFFAOYSA-N 0.000 description 1
- KOMHXZUPKHZEBA-UHFFFAOYSA-N 2-fluoro-8-[[6-(furan-2-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCNCC(C)C)C=1CC1=CC=2OCCOC=2C=C1C1=CC=CO1 KOMHXZUPKHZEBA-UHFFFAOYSA-N 0.000 description 1
- RXYROHNFNCMLEP-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[(1-methyl-6-pyrrolidin-1-yl-3,4-dihydro-2H-quinolin-7-yl)methyl]purin-6-amine Chemical compound FC1=NC(=C2N=C(N(C2=N1)CCNCC(C)C)CC1=C(C=C2CCCN(C2=C1)C)N1CCCC1)N RXYROHNFNCMLEP-UHFFFAOYSA-N 0.000 description 1
- YZUMOFJLBCWSOY-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[(6-thiophen-2-yl-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]purin-6-amine Chemical compound FC1=NC(=C2N=C(N(C2=N1)CCNCC(C)C)CC1=CC2=C(OCCO2)C=C1C=1SC=CC=1)N YZUMOFJLBCWSOY-UHFFFAOYSA-N 0.000 description 1
- YKDMHDHNBIRJDO-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[(6-thiophen-3-yl-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]purin-6-amine Chemical compound FC1=NC(=C2N=C(N(C2=N1)CCNCC(C)C)CC1=CC2=C(OCCO2)C=C1C1=CSC=C1)N YKDMHDHNBIRJDO-UHFFFAOYSA-N 0.000 description 1
- AJLLYQFEZSGBOI-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[(7-pyrrolidin-1-yl-1,2,3,4-tetrahydroquinolin-6-yl)methyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCNCC(C)C)C=1CC1=CC=2CCCNC=2C=C1N1CCCC1 AJLLYQFEZSGBOI-UHFFFAOYSA-N 0.000 description 1
- KNTDVDXGMWNTSB-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[(7-pyrrolidin-1-yl-2,3-dihydro-1,4-benzoxathiin-6-yl)methyl]purin-6-amine Chemical compound FC1=NC(=C2N=C(N(C2=N1)CCNCC(C)C)CC1=CC2=C(OCCS2)C=C1N1CCCC1)N KNTDVDXGMWNTSB-UHFFFAOYSA-N 0.000 description 1
- MGHHXQKKRILVGV-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[[6-(1h-pyrazol-4-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCNCC(C)C)C=1CC1=CC=2OCCOC=2C=C1C=1C=NNC=1 MGHHXQKKRILVGV-UHFFFAOYSA-N 0.000 description 1
- YMBJWEMHCASNCN-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[[6-(1h-pyrrol-3-yl)-1-benzothiophen-5-yl]methyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCNCC(C)C)C=1CC1=CC=2C=CSC=2C=C1C=1C=CNC=1 YMBJWEMHCASNCN-UHFFFAOYSA-N 0.000 description 1
- FAHQGJGOGNXSMF-UHFFFAOYSA-N 2-fluoro-9-[2-(2-methylpropylamino)ethyl]-8-[[6-(propan-2-ylamino)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-6-amine Chemical compound FC1=NC(=C2N=C(N(C2=N1)CCNCC(C)C)CC1=CC2=C(OCCO2)C=C1NC(C)C)N FAHQGJGOGNXSMF-UHFFFAOYSA-N 0.000 description 1
- UOBYKYZJUGYBDK-UHFFFAOYSA-N 2-naphthoic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CC=C21 UOBYKYZJUGYBDK-UHFFFAOYSA-N 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- VPOBKLPLJLKYPO-UHFFFAOYSA-N 3-[2-[6-amino-8-[[6-(1H-pyrazol-5-yl)-2,3-dihydro-1H-inden-5-yl]sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde Chemical compound Nc1ncnc2n(CCC3CCCN(C3)C=O)c(Sc3cc4CCCc4cc3-c3cc[nH]n3)nc12 VPOBKLPLJLKYPO-UHFFFAOYSA-N 0.000 description 1
- ACKXKWUWHXJEDA-UHFFFAOYSA-N 3-[6-amino-9-[3-(propan-2-ylamino)propyl]purin-8-yl]sulfanyl-5,6,7,8-tetrahydronaphthalene-2-carbonitrile Chemical compound NC1=C2N=C(N(C2=NC=N1)CCCNC(C)C)SC=1C(=CC=2CCCCC=2C=1)C#N ACKXKWUWHXJEDA-UHFFFAOYSA-N 0.000 description 1
- FVMDYYGIDFPZAX-UHFFFAOYSA-N 3-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=CC(O)=C1 FVMDYYGIDFPZAX-UHFFFAOYSA-N 0.000 description 1
- KAOTXIGLMDOHJJ-UHFFFAOYSA-N 3-iodonaphthalen-2-amine Chemical compound C1=CC=C2C=C(I)C(N)=CC2=C1 KAOTXIGLMDOHJJ-UHFFFAOYSA-N 0.000 description 1
- PLHJCCHSCFNKCC-UHFFFAOYSA-N 3-methylpent-1-yne Chemical group CCC(C)C#C PLHJCCHSCFNKCC-UHFFFAOYSA-N 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- UNTNRNUQVKDIPV-UHFFFAOYSA-N 3h-dithiazole Chemical compound N1SSC=C1 UNTNRNUQVKDIPV-UHFFFAOYSA-N 0.000 description 1
- SLKTYXFCYMDNID-UHFFFAOYSA-N 4-[2-[6-amino-2-chloro-8-[[6-(1,2-oxazol-4-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde Chemical compound C=1C=2OCCOC=2C=C(C2=CON=C2)C=1CC1=NC=2C(N)=NC(Cl)=NC=2N1CCC1CCN(C=O)CC1 SLKTYXFCYMDNID-UHFFFAOYSA-N 0.000 description 1
- WREWDEMQVZQKOJ-UHFFFAOYSA-N 4-[2-[6-amino-8-[(6-ethynyl-4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde Chemical compound NC1=C2N=C(N(C2=NC=N1)CCC1CCN(CC1)C=O)SC=1C(=CC2=C(OCCN2C)C=1)C#C WREWDEMQVZQKOJ-UHFFFAOYSA-N 0.000 description 1
- DCHQWGGBFQSJEX-UHFFFAOYSA-N 4-[2-[6-amino-8-[(7-thiophen-3-yl-2,3-dihydro-1,4-benzodioxin-6-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde Chemical compound Nc1ncnc2n(CCC3CCN(CC3)C=O)c(Sc3cc4OCCOc4cc3-c3ccsc3)nc12 DCHQWGGBFQSJEX-UHFFFAOYSA-N 0.000 description 1
- OQUNQUNFBBMQLT-UHFFFAOYSA-N 4-[2-[6-amino-8-[[6-(furan-2-yl)-4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl]sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde Chemical compound C=1C=COC=1C=1C=C2N(C)CCOC2=CC=1SC1=NC2=C(N)N=CN=C2N1CCC1CCN(C=O)CC1 OQUNQUNFBBMQLT-UHFFFAOYSA-N 0.000 description 1
- YUPZQRUUSZQMJT-UHFFFAOYSA-N 4-[2-[6-amino-8-[[7-(furan-2-yl)-1-methyl-3,4-dihydro-2h-quinolin-6-yl]sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde Chemical compound C=1C=COC=1C=1C=C2N(C)CCCC2=CC=1SC1=NC2=C(N)N=CN=C2N1CCC1CCN(C=O)CC1 YUPZQRUUSZQMJT-UHFFFAOYSA-N 0.000 description 1
- ZTBQQMRMUWBAOB-UHFFFAOYSA-N 4-methyl-2,3-dihydro-1,4-benzoxazin-6-amine Chemical compound C1=C(N)C=C2N(C)CCOC2=C1 ZTBQQMRMUWBAOB-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- YQGADULPCIXSJV-UHFFFAOYSA-N 5-iodo-2,3-dihydro-1-benzofuran-6-amine Chemical compound C1=C(I)C(N)=CC2=C1CCO2 YQGADULPCIXSJV-UHFFFAOYSA-N 0.000 description 1
- XGGFGVBDRQQERB-UHFFFAOYSA-N 6-[6-amino-9-[2-(2-methylpropylamino)ethyl]purin-8-yl]sulfanyl-5-iodo-2,3-dihydroinden-1-one Chemical compound N1=CN=C2N(CCNCC(C)C)C(SC=3C(=CC=4CCC(=O)C=4C=3)I)=NC2=C1N XGGFGVBDRQQERB-UHFFFAOYSA-N 0.000 description 1
- GYNZCMPPAAIVND-UHFFFAOYSA-N 6-[6-amino-9-[2-(2-methylpropylamino)ethyl]purin-8-yl]sulfanyl-5-iodo-2,3-dihydroindene-1-thione Chemical compound CC(C)CNCCn1c(Sc2cc3C(=S)CCc3cc2I)nc2c(N)ncnc12 GYNZCMPPAAIVND-UHFFFAOYSA-N 0.000 description 1
- DRWASPXCHAZFAI-UHFFFAOYSA-N 6-[6-amino-9-[3-(propan-2-ylamino)propyl]purin-8-yl]sulfanyl-2,3-dihydro-1h-indole-5-carbonitrile Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCNC=4C=3)C#N)=NC2=C1N DRWASPXCHAZFAI-UHFFFAOYSA-N 0.000 description 1
- GFWXKEOIVDAOBG-UHFFFAOYSA-N 6-[6-amino-9-[3-(propan-2-ylamino)propyl]purin-8-yl]sulfanyl-5-cyclopropyl-2,3-dihydroinden-1-one Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2C(=O)CCC=2C=C1C1CC1 GFWXKEOIVDAOBG-UHFFFAOYSA-N 0.000 description 1
- LZZBEUQNJFBTEZ-UHFFFAOYSA-N 6-[6-amino-9-[3-(propan-2-ylamino)propyl]purin-8-yl]sulfanyl-5-iodo-2,3-dihydroinden-1-one Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCC(=O)C=4C=3)I)=NC2=C1N LZZBEUQNJFBTEZ-UHFFFAOYSA-N 0.000 description 1
- ZFXQTYAHIQFBNG-UHFFFAOYSA-N 6-[6-amino-9-[3-(tert-butylamino)propyl]purin-8-yl]sulfanyl-5-iodo-2,3-dihydroinden-1-one Chemical compound N1=CN=C2N(CCCNC(C)(C)C)C(SC=3C(=CC=4CCC(=O)C=4C=3)I)=NC2=C1N ZFXQTYAHIQFBNG-UHFFFAOYSA-N 0.000 description 1
- JYZVDGQFWOSVHT-UHFFFAOYSA-N 6-[[6-amino-2-fluoro-9-[2-(2-methylpropylamino)ethyl]purin-8-yl]methyl]-5-ethynyl-2,3-dihydroinden-1-one Chemical compound N1=C(F)N=C2N(CCNCC(C)C)C(CC=3C(=CC=4CCC(=O)C=4C=3)C#C)=NC2=C1N JYZVDGQFWOSVHT-UHFFFAOYSA-N 0.000 description 1
- VYNLYXAINVRGLE-UHFFFAOYSA-N 6-[[6-amino-2-fluoro-9-[3-(propan-2-ylamino)propyl]purin-8-yl]methyl]-2,3-dihydro-1-benzothiophene-5-carbonitrile Chemical compound N1=C(F)N=C2N(CCCNC(C)C)C(CC=3C(=CC=4CCSC=4C=3)C#N)=NC2=C1N VYNLYXAINVRGLE-UHFFFAOYSA-N 0.000 description 1
- HZTMYTXWFHBHDC-UHFFFAOYSA-N 6-iodo-2,3-dihydro-1,4-benzodioxine Chemical compound O1CCOC2=CC(I)=CC=C21 HZTMYTXWFHBHDC-UHFFFAOYSA-N 0.000 description 1
- UPHIJLSUBXGZDN-UHFFFAOYSA-N 6-iodo-2,3-dihydro-1h-inden-5-amine Chemical compound C1=C(I)C(N)=CC2=C1CCC2 UPHIJLSUBXGZDN-UHFFFAOYSA-N 0.000 description 1
- WFHLBXBWGXRUFO-UHFFFAOYSA-N 6-iodo-4-methyl-2,3-dihydro-1,4-benzoxazine Chemical compound C1=C(I)C=C2N(C)CCOC2=C1 WFHLBXBWGXRUFO-UHFFFAOYSA-N 0.000 description 1
- HLUYEDQKIFUIIP-UHFFFAOYSA-N 6-nitro-2,3-dihydro-1h-inden-5-amine Chemical compound C1=C([N+]([O-])=O)C(N)=CC2=C1CCC2 HLUYEDQKIFUIIP-UHFFFAOYSA-N 0.000 description 1
- GZAJZBARYACGSO-UHFFFAOYSA-N 6-nitro-3,4-dihydro-2h-1,4-benzoxazine Chemical compound O1CCNC2=CC([N+](=O)[O-])=CC=C21 GZAJZBARYACGSO-UHFFFAOYSA-N 0.000 description 1
- SKNSJXBJCQTNEA-UHFFFAOYSA-N 7-[[6-amino-2-chloro-9-[2-(2-methylpropylamino)ethyl]purin-8-yl]methyl]-2,3-dihydro-1,4-benzodioxine-6-carbonitrile Chemical compound N1=C(Cl)N=C2N(CCNCC(C)C)C(CC=3C(=CC=4OCCOC=4C=3)C#N)=NC2=C1N SKNSJXBJCQTNEA-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BSOSYDPCRDZIPG-UHFFFAOYSA-N 8-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-2-fluoro-7h-purin-6-amine Chemical compound O1CCOC2=CC(CC=3NC=4N=C(F)N=C(C=4N=3)N)=CC=C21 BSOSYDPCRDZIPG-UHFFFAOYSA-N 0.000 description 1
- MYIXDYQABWOTGD-UHFFFAOYSA-N 8-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-7h-purine-2,6-diamine Chemical compound O1CCOC2=CC(CC3=NC4=C(N)N=C(N=C4N3)N)=CC=C21 MYIXDYQABWOTGD-UHFFFAOYSA-N 0.000 description 1
- IJGNXHMGSHWYMI-UHFFFAOYSA-N 8-(2,3-dihydro-1-benzofuran-6-ylmethyl)-2-fluoro-7h-purin-6-amine Chemical compound C1=C2CCOC2=CC(CC=2NC=3N=C(F)N=C(C=3N=2)N)=C1 IJGNXHMGSHWYMI-UHFFFAOYSA-N 0.000 description 1
- DSPTXZGHDKLHKT-UHFFFAOYSA-N 8-(2,3-dihydro-1-benzofuran-6-ylmethyl)-7h-purine-2,6-diamine Chemical compound C1=C2CCOC2=CC(CC2=NC3=C(N)N=C(N=C3N2)N)=C1 DSPTXZGHDKLHKT-UHFFFAOYSA-N 0.000 description 1
- QBDIWVWILFTKMA-UHFFFAOYSA-N 8-(2,3-dihydro-1-benzofuran-6-ylsulfanyl)-7h-purin-6-amine Chemical compound C1=C2CCOC2=CC(SC=2NC=3N=CN=C(C=3N=2)N)=C1 QBDIWVWILFTKMA-UHFFFAOYSA-N 0.000 description 1
- KLMFUVMHWUPKHW-UHFFFAOYSA-N 8-(2-ethynyl-5-methoxyphenyl)sulfanyl-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound COC1=CC=C(C#C)C(SC=2N(C3=NC=NC(N)=C3N=2)CCNCC(C)C)=C1 KLMFUVMHWUPKHW-UHFFFAOYSA-N 0.000 description 1
- HBTAVDQMKRPVHE-UHFFFAOYSA-N 8-(2-ethynyl-5-methoxyphenyl)sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound COC1=CC=C(C#C)C(SC=2N(C3=NC=NC(N)=C3N=2)CCCNC(C)C)=C1 HBTAVDQMKRPVHE-UHFFFAOYSA-N 0.000 description 1
- JJMVOSZFKUVWDI-UHFFFAOYSA-N 8-(3-aminonaphthalen-2-yl)sulfanyl-7h-purin-6-amine Chemical compound N1=CN=C2NC(SC3=CC4=CC=CC=C4C=C3N)=NC2=C1N JJMVOSZFKUVWDI-UHFFFAOYSA-N 0.000 description 1
- TYPMZTJRNARGNL-UHFFFAOYSA-N 8-(3-ethynylnaphthalen-2-yl)sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC4=CC=CC=C4C=3)C#C)=NC2=C1N TYPMZTJRNARGNL-UHFFFAOYSA-N 0.000 description 1
- SQLMTMCDBGCHEF-UHFFFAOYSA-N 8-(3-iodonaphthalen-2-yl)sulfanyl-7h-purin-6-amine Chemical compound C1=CC=C2C=C(I)C(SC=3NC=4N=CN=C(C=4N=3)N)=CC2=C1 SQLMTMCDBGCHEF-UHFFFAOYSA-N 0.000 description 1
- KAAKYCMZWOXTJG-UHFFFAOYSA-N 8-(5-methoxy-2-thiophen-3-ylphenyl)sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC(OC)=CC=C1C=1C=CSC=1 KAAKYCMZWOXTJG-UHFFFAOYSA-N 0.000 description 1
- HDSHZLGIUMZWSB-UHFFFAOYSA-N 8-[(3-ethynyl-5,6,7,8-tetrahydronaphthalen-2-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCCCC=4C=3)C#C)=NC2=C1N HDSHZLGIUMZWSB-UHFFFAOYSA-N 0.000 description 1
- XTQRXKNWJNNOND-UHFFFAOYSA-N 8-[(3-iodo-5,6,7,8-tetrahydronaphthalen-2-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound IC=1C(=CC=2CCCCC=2C=1)SC=1N(C2=NC=NC(=C2N=1)N)CCCNC(C)C XTQRXKNWJNNOND-UHFFFAOYSA-N 0.000 description 1
- NUUUCQLVMGYZGS-UHFFFAOYSA-N 8-[(4-methyl-6-thiophen-2-yl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound C(C)(C)NCCCN1C2=NC=NC(=C2N=C1SC=1C(=CC2=C(OCCN2C)C=1)C=1SC=CC=1)N NUUUCQLVMGYZGS-UHFFFAOYSA-N 0.000 description 1
- YXHHEVCURMCQEO-UHFFFAOYSA-N 8-[(5-ethynyl-1h-indol-6-yl)sulfanyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)C)C(SC=3C(=CC=4C=CNC=4C=3)C#C)=NC2=C1N YXHHEVCURMCQEO-UHFFFAOYSA-N 0.000 description 1
- YXJWGLAMUNDZBL-UHFFFAOYSA-N 8-[(5-ethynyl-2,3-dihydro-1-benzofuran-6-yl)methyl]-2-fluoro-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCNCC(C)C)C(CC=3C(=CC=4CCOC=4C=3)C#C)=NC2=C1N YXJWGLAMUNDZBL-UHFFFAOYSA-N 0.000 description 1
- QZFVWMWGRKKLLQ-UHFFFAOYSA-N 8-[(5-iodo-1-benzofuran-6-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound CC(C)NCCCn1c(Sc2cc3occc3cc2I)nc2c(N)ncnc12 QZFVWMWGRKKLLQ-UHFFFAOYSA-N 0.000 description 1
- PTJPWVWSBBXEOC-UHFFFAOYSA-N 8-[(5-iodo-1-benzothiophen-6-yl)sulfanyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)C)C(SC=3C(=CC=4C=CSC=4C=3)I)=NC2=C1N PTJPWVWSBBXEOC-UHFFFAOYSA-N 0.000 description 1
- LWIYELFYGFDKKQ-UHFFFAOYSA-N 8-[(5-iodo-1-methyl-2,3-dihydroindol-6-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCN(C)C=4C=3)I)=NC2=C1N LWIYELFYGFDKKQ-UHFFFAOYSA-N 0.000 description 1
- QTCOVPRGVVTMJX-UHFFFAOYSA-N 8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)sulfanyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)C)C(SC=3C(=CC=4CCOC=4C=3)I)=NC2=C1N QTCOVPRGVVTMJX-UHFFFAOYSA-N 0.000 description 1
- MZWFMXHWZJGGMO-UHFFFAOYSA-N 8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCOC=4C=3)I)=NC2=C1N MZWFMXHWZJGGMO-UHFFFAOYSA-N 0.000 description 1
- XJOVJTWGCIDQQC-UHFFFAOYSA-N 8-[(5-iodo-2,3-dihydro-1-benzothiophen-6-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCSC=4C=3)I)=NC2=C1N XJOVJTWGCIDQQC-UHFFFAOYSA-N 0.000 description 1
- XPFTXWUUMGLYEB-UHFFFAOYSA-N 8-[(6-amino-2,3-dihydro-1-benzofuran-5-yl)sulfanyl]-7h-purin-6-amine Chemical compound N1=CN=C2NC(SC3=CC=4CCOC=4C=C3N)=NC2=C1N XPFTXWUUMGLYEB-UHFFFAOYSA-N 0.000 description 1
- JGZZQCJAAZNYPG-UHFFFAOYSA-N 8-[(6-cyclobutyl-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]-2-fluoro-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound C1(CCC1)C=1C(=CC2=C(OCCO2)C1)CC=1N(C2=NC(=NC(=C2N1)N)F)CCNCC(C)C JGZZQCJAAZNYPG-UHFFFAOYSA-N 0.000 description 1
- GLEFJNSPLRHGFO-UHFFFAOYSA-N 8-[(6-ethynyl-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4OCOC=4C=3)C#C)=NC2=C1N GLEFJNSPLRHGFO-UHFFFAOYSA-N 0.000 description 1
- AEKAFBSTUWORMU-UHFFFAOYSA-N 8-[(6-ethynyl-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]-2-fluoro-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound C(#C)C=1C(=CC2=C(OCCO2)C1)CC=1N(C2=NC(=NC(=C2N1)N)F)CCC1CN(CCC1)S(=O)(=O)C AEKAFBSTUWORMU-UHFFFAOYSA-N 0.000 description 1
- STDQCFFHUJXNKM-UHFFFAOYSA-N 8-[(6-ethynyl-2,3-dihydro-1h-inden-5-yl)methyl]-2-fluoro-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCCNC(C)C)C(CC=3C(=CC=4CCCC=4C=3)C#C)=NC2=C1N STDQCFFHUJXNKM-UHFFFAOYSA-N 0.000 description 1
- ZWFYLHNKBFJUAO-UHFFFAOYSA-N 8-[(6-ethynyl-2,3-dihydro-1h-inden-5-yl)sulfanyl]-9-[2-(1-methylpiperidin-2-yl)ethyl]purin-6-amine Chemical compound CN1CCCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C#C)=CC2=C1CCC2 ZWFYLHNKBFJUAO-UHFFFAOYSA-N 0.000 description 1
- YHQSVNZDCAAXBV-UHFFFAOYSA-N 8-[(6-ethynyl-2,3-dihydro-1h-inden-5-yl)sulfanyl]-9-[2-(1-methylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound C1N(C)CCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C#C)=CC2=C1CCC2 YHQSVNZDCAAXBV-UHFFFAOYSA-N 0.000 description 1
- YHLAVTCZFZVGCX-UHFFFAOYSA-N 8-[(6-ethynyl-2,3-dihydro-1h-inden-5-yl)sulfanyl]-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound C1N(S(=O)(=O)C)CCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C#C)=CC2=C1CCC2 YHLAVTCZFZVGCX-UHFFFAOYSA-N 0.000 description 1
- PBADZXDQQDMYCL-UHFFFAOYSA-N 8-[(6-ethynyl-2,3-dihydro-1h-inden-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCCC=4C=3)C#C)=NC2=C1N PBADZXDQQDMYCL-UHFFFAOYSA-N 0.000 description 1
- OTGVQCGPYKIZSN-UHFFFAOYSA-N 8-[(6-ethynyl-3,4-dihydro-2h-thiochromen-7-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4CCCSC=4C=3)C#C)=NC2=C1N OTGVQCGPYKIZSN-UHFFFAOYSA-N 0.000 description 1
- WQSGPJCMKZBDNJ-UHFFFAOYSA-N 8-[(6-iodo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]-7h-purin-6-amine Chemical compound O1CCOC(C=C2I)=C1C=C2SC(N1)=NC2=C1N=CN=C2N WQSGPJCMKZBDNJ-UHFFFAOYSA-N 0.000 description 1
- OGVPPEHQZFHZET-UHFFFAOYSA-N 8-[(6-iodo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4OCCOC=4C=3)I)=NC2=C1N OGVPPEHQZFHZET-UHFFFAOYSA-N 0.000 description 1
- AGPIGMGCFKFFFQ-UHFFFAOYSA-N 8-[(6-iodo-2,3-dihydro-1-benzofuran-5-yl)sulfanyl]-7h-purin-6-amine Chemical compound N=1C=2C(N)=NC=NC=2NC=1SC(C(=C1)I)=CC2=C1OCC2 AGPIGMGCFKFFFQ-UHFFFAOYSA-N 0.000 description 1
- NUZQGTULLXBAPU-UHFFFAOYSA-N 8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)sulfanyl]-7h-purin-6-amine Chemical compound N=1C=2C(N)=NC=NC=2NC=1SC(C(=C1)I)=CC2=C1CCC2 NUZQGTULLXBAPU-UHFFFAOYSA-N 0.000 description 1
- CULDUFHOZXWPGC-UHFFFAOYSA-N 8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)sulfanyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)C)C(SC=3C(=CC=4CCCC=4C=3)I)=NC2=C1N CULDUFHOZXWPGC-UHFFFAOYSA-N 0.000 description 1
- BKFKGZDLYGZNDB-UHFFFAOYSA-N 8-[(6-iodo-2,3-dihydro-1h-indol-5-yl)sulfanyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)C)C(SC=3C(=CC=4NCCC=4C=3)I)=NC2=C1N BKFKGZDLYGZNDB-UHFFFAOYSA-N 0.000 description 1
- NJUNNPVXVQSUEV-UHFFFAOYSA-N 8-[(7-ethynyl-2,3-dihydro-1,4-benzodioxin-6-yl)sulfanyl]-9-[2-(1-methylpiperidin-2-yl)ethyl]purin-6-amine Chemical compound CN1CCCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C#C)=CC2=C1OCCO2 NJUNNPVXVQSUEV-UHFFFAOYSA-N 0.000 description 1
- OCBAMJRUQRBHKQ-UHFFFAOYSA-N 8-[(7-ethynyl-2,3-dihydro-1,4-benzodioxin-6-yl)sulfanyl]-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound C1N(S(=O)(=O)C)CCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C#C)=CC2=C1OCCO2 OCBAMJRUQRBHKQ-UHFFFAOYSA-N 0.000 description 1
- GAZBXNGSFSYIIK-UHFFFAOYSA-N 8-[(7-ethynyl-2,3-dihydro-1,4-benzoxathiin-6-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4OCCSC=4C=3)C#C)=NC2=C1N GAZBXNGSFSYIIK-UHFFFAOYSA-N 0.000 description 1
- LPKXDAFUMBTXAK-UHFFFAOYSA-N 8-[(7-iodo-2,3-dihydro-1,4-benzoxathiin-6-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4OCCSC=4C=3)I)=NC2=C1N LPKXDAFUMBTXAK-UHFFFAOYSA-N 0.000 description 1
- XSUYWIWBQHYGOR-UHFFFAOYSA-N 8-[(7-iodo-3,4-dihydro-2H-chromen-6-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4OCCCC=4C=3)I)=NC2=C1N XSUYWIWBQHYGOR-UHFFFAOYSA-N 0.000 description 1
- IFFUEBJXJSVBHL-UHFFFAOYSA-N 8-[2-[5-(aminomethyl)furan-2-yl]-5-methoxyphenyl]sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound NCC1=CC=C(O1)C1=C(C=C(C=C1)OC)SC=1N(C2=NC=NC(=C2N=1)N)CCCNC(C)C IFFUEBJXJSVBHL-UHFFFAOYSA-N 0.000 description 1
- FBFUCSWYZQQTOW-UHFFFAOYSA-N 8-[3-(5-methyl-1,3-oxazol-2-yl)naphthalen-2-yl]sulfanyl-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound O1C(C)=CN=C1C1=CC2=CC=CC=C2C=C1SC1=NC2=C(N)N=CN=C2N1CCC1CN(S(C)(=O)=O)CCC1 FBFUCSWYZQQTOW-UHFFFAOYSA-N 0.000 description 1
- TVNKNXVPDSZRIG-UHFFFAOYSA-N 8-[5-methoxy-2-(1,2-oxazol-4-yl)phenyl]sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound C(C)(C)NCCCN1C2=NC=NC(=C2N=C1SC1=C(C=CC(=C1)OC)C=1C=NOC=1)N TVNKNXVPDSZRIG-UHFFFAOYSA-N 0.000 description 1
- BZBGPUSZYPZVHJ-UHFFFAOYSA-N 8-[5-methoxy-2-(2-phenylethynyl)phenyl]sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound COc1ccc(C#Cc2ccccc2)c(Sc2nc3c(N)ncnc3n2CCCNC(C)C)c1 BZBGPUSZYPZVHJ-UHFFFAOYSA-N 0.000 description 1
- ZIYPFZVRTLLCGW-UHFFFAOYSA-N 8-[5-methoxy-2-(5-methylfuran-2-yl)phenyl]sulfanyl-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound COc1ccc(-c2ccc(C)o2)c(Sc2nc3c(N)ncnc3n2CCC2CCCN(C2)S(C)(=O)=O)c1 ZIYPFZVRTLLCGW-UHFFFAOYSA-N 0.000 description 1
- OJSIRSOQNBUVBR-UHFFFAOYSA-N 8-[5-methoxy-2-(5-methylthiophen-2-yl)phenyl]sulfanyl-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCC2CN(CCC2)S(C)(=O)=O)C=1SC1=CC(OC)=CC=C1C1=CC=C(C)S1 OJSIRSOQNBUVBR-UHFFFAOYSA-N 0.000 description 1
- HQBHYYBULDVODB-UHFFFAOYSA-N 8-[6-(furan-2-yl)-1-methylindol-5-yl]sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2C=CN(C)C=2C=C1C1=CC=CO1 HQBHYYBULDVODB-UHFFFAOYSA-N 0.000 description 1
- XDKWSVYHTXTMQT-UHFFFAOYSA-N 8-[[3-(dimethylamino)-5,6,7,8-tetrahydronaphthalen-2-yl]sulfanyl]-9-[2-(2,2-dimethylpropylamino)ethyl]purin-6-amine Chemical compound CN(C=1C(=CC=2CCCCC=2C=1)SC=1N(C2=NC=NC(=C2N=1)N)CCNCC(C)(C)C)C XDKWSVYHTXTMQT-UHFFFAOYSA-N 0.000 description 1
- ZNGKFDSBGRNRGT-UHFFFAOYSA-N 8-[[5-(azetidin-1-yl)-1-benzofuran-6-yl]sulfanyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)C)C=1SC1=CC=2OC=CC=2C=C1N1CCC1 ZNGKFDSBGRNRGT-UHFFFAOYSA-N 0.000 description 1
- GEVDPJAKJKBPCV-UHFFFAOYSA-N 8-[[5-(furan-2-yl)-1-methyl-2,3-dihydroindol-6-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2N(C)CCC=2C=C1C1=CC=CO1 GEVDPJAKJKBPCV-UHFFFAOYSA-N 0.000 description 1
- HMPHCWKSKTWAJL-UHFFFAOYSA-N 8-[[5-(furan-2-yl)-2,3-dihydro-1-benzothiophen-6-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2SCCC=2C=C1C1=CC=CO1 HMPHCWKSKTWAJL-UHFFFAOYSA-N 0.000 description 1
- DWJAASBVGZLXTI-UHFFFAOYSA-N 8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1h-inden-5-yl]sulfanyl]-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound O1C(C)=CN=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCC2CN(CCC2)S(C)(=O)=O)=CC2=C1CCC2 DWJAASBVGZLXTI-UHFFFAOYSA-N 0.000 description 1
- SWPGGAYUTFURMR-UHFFFAOYSA-N 8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1h-inden-5-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2CCCC=2C=C1C1=NC=C(C)O1 SWPGGAYUTFURMR-UHFFFAOYSA-N 0.000 description 1
- GKZPTDAGXPRHGO-UHFFFAOYSA-N 8-[[6-(5-methylfuran-2-yl)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound C(C)(C)NCCCN1C2=NC=NC(=C2N=C1SC=1C(=CC2=C(CCO2)C=1)C=1OC(=CC=1)C)N GKZPTDAGXPRHGO-UHFFFAOYSA-N 0.000 description 1
- IJYXAPXQQUNNPH-UHFFFAOYSA-N 8-[[6-(aziridin-1-yl)-2,3-dihydro-1h-inden-5-yl]sulfanyl]-9-[3-(1-methylsulfonylpyrrolidin-3-yl)propyl]purin-6-amine Chemical compound C1N(S(=O)(=O)C)CCC1CCCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)N2CC2)=CC2=C1CCC2 IJYXAPXQQUNNPH-UHFFFAOYSA-N 0.000 description 1
- QBKWGGUJUXOAJI-UHFFFAOYSA-N 8-[[6-(dimethylamino)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound CN(C)C1=CC=2OCCC=2C=C1SC1=NC2=C(N)N=CN=C2N1CCC1CCCN(S(C)(=O)=O)C1 QBKWGGUJUXOAJI-UHFFFAOYSA-N 0.000 description 1
- VTDGIAKKUGATJS-UHFFFAOYSA-N 8-[[6-(furan-2-yl)-1-methyl-2,3-dihydroindol-5-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2CCN(C)C=2C=C1C1=CC=CO1 VTDGIAKKUGATJS-UHFFFAOYSA-N 0.000 description 1
- LXGGEZUWOZFYJJ-UHFFFAOYSA-N 8-[[6-(furan-2-yl)-2,3-dihydro-1,4-benzoxathiin-7-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2OCCSC=2C=C1C1=CC=CO1 LXGGEZUWOZFYJJ-UHFFFAOYSA-N 0.000 description 1
- IMQGFDCXFBQAPC-UHFFFAOYSA-N 8-[[6-(furan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound C1N(S(=O)(=O)C)CCCC1CCN1C2=NC=NC(N)=C2N=C1SC(C(=C1)C=2OC=CC=2)=CC2=C1OCC2 IMQGFDCXFBQAPC-UHFFFAOYSA-N 0.000 description 1
- KRXKYEIIXSRGCU-UHFFFAOYSA-N 8-[[6-(furan-2-yl)-2,3-dihydro-1H-inden-5-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound CC(C)NCCCn1c(Sc2cc3CCCc3cc2-c2ccco2)nc2c(N)ncnc12 KRXKYEIIXSRGCU-UHFFFAOYSA-N 0.000 description 1
- MUGGGVXWICQHOU-UHFFFAOYSA-N 8-[[7-(1,3-oxazol-2-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2OCCOC=2C=C1C1=NC=CO1 MUGGGVXWICQHOU-UHFFFAOYSA-N 0.000 description 1
- CLEHINJCGAOGHE-UHFFFAOYSA-N 8-[[7-(1h-imidazol-5-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2OCCOC=2C=C1C1=CN=CN1 CLEHINJCGAOGHE-UHFFFAOYSA-N 0.000 description 1
- UYOVTBUSTPCHKR-UHFFFAOYSA-N 8-[[7-(5-methyl-1h-pyrazol-3-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2OCCOC=2C=C1C=1C=C(C)NN=1 UYOVTBUSTPCHKR-UHFFFAOYSA-N 0.000 description 1
- XOPYRYPWSGYTNS-UHFFFAOYSA-N 8-[[7-(azetidin-1-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]-9-[2-(2-methylpropylamino)ethyl]purin-6-amine Chemical compound N1(CCC1)C=1C(=CC2=C(OCCO2)C=1)SC=1N(C2=NC=NC(=C2N=1)N)CCNCC(C)C XOPYRYPWSGYTNS-UHFFFAOYSA-N 0.000 description 1
- AMHJZMVHWYRESC-UHFFFAOYSA-N 8-[[7-(dimethylamino)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)C)C(SC=3C(=CC=4OCCOC=4C=3)N(C)C)=NC2=C1N AMHJZMVHWYRESC-UHFFFAOYSA-N 0.000 description 1
- SFPHHBCWGMJHDU-UHFFFAOYSA-N 8-[[7-(ethylamino)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]-9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]purin-6-amine Chemical compound CCNC1=CC=2OCCOC=2C=C1SC1=NC2=C(N)N=CN=C2N1CCC1CCCN(S(C)(=O)=O)C1 SFPHHBCWGMJHDU-UHFFFAOYSA-N 0.000 description 1
- AZSXXMOJXHASGY-UHFFFAOYSA-N 8-[[7-(furan-2-yl)-2,3-dihydro-1,4-benzoxathiin-6-yl]sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2SCCOC=2C=C1C1=CC=CO1 AZSXXMOJXHASGY-UHFFFAOYSA-N 0.000 description 1
- SHQAZVGKHVPSMC-UHFFFAOYSA-N 9-(2-aminoethyl)-2-fluoro-8-[[6-(1h-pyrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCN)C=1CC1=CC=2OCCOC=2C=C1C1=CC=NN1 SHQAZVGKHVPSMC-UHFFFAOYSA-N 0.000 description 1
- UYOFMNBRDKMOFB-UHFFFAOYSA-N 9-(2-aminoethyl)-8-[(5-iodo-1-benzofuran-6-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCN)C(SC=3C(=CC=4C=COC=4C=3)I)=NC2=C1N UYOFMNBRDKMOFB-UHFFFAOYSA-N 0.000 description 1
- QRDITXFUELRFTL-UHFFFAOYSA-N 9-(2-aminoethyl)-8-[(6-iodo-1-benzofuran-5-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCN)C(SC=3C(=CC=4OC=CC=4C=3)I)=NC2=C1N QRDITXFUELRFTL-UHFFFAOYSA-N 0.000 description 1
- ZTMCFEKXHPYMKI-UHFFFAOYSA-N 9-(2-aminoethyl)-8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCN)C(SC=3C(=CC=4CCCC=4C=3)I)=NC2=C1N ZTMCFEKXHPYMKI-UHFFFAOYSA-N 0.000 description 1
- SERDKQSFCYHJER-UHFFFAOYSA-N 9-(2-bromoethyl)-2-fluoro-8-[(6-iodo-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]purin-6-amine Chemical compound O1CCOC(C=C2I)=C1C=C2CC(N1CCBr)=NC2=C1N=C(F)N=C2N SERDKQSFCYHJER-UHFFFAOYSA-N 0.000 description 1
- HQDYUQMYJMUVOC-UHFFFAOYSA-N 9-(2-bromoethyl)-8-[(6-iodo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]purin-6-amine Chemical compound O1CCOC(C=C2I)=C1C=C2SC(N1CCBr)=NC2=C1N=CN=C2N HQDYUQMYJMUVOC-UHFFFAOYSA-N 0.000 description 1
- WBJHBCYKTBUULP-UHFFFAOYSA-N 9-(2-bromoethyl)-8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)sulfanyl]purin-6-amine Chemical compound N=1C=2C(N)=NC=NC=2N(CCBr)C=1SC(C(=C1)I)=CC2=C1CCC2 WBJHBCYKTBUULP-UHFFFAOYSA-N 0.000 description 1
- ZWTUZOCDDIACIA-UHFFFAOYSA-N 9-(3-aminopropyl)-2-fluoro-8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-6-amine Chemical compound O1C(C)=CN=C1C(C(=C1)CC=2N(C3=NC(F)=NC(N)=C3N=2)CCCN)=CC2=C1OCCO2 ZWTUZOCDDIACIA-UHFFFAOYSA-N 0.000 description 1
- BACXBYWHORYCAF-UHFFFAOYSA-N 9-(3-aminopropyl)-8-[(5-iodo-1-benzofuran-6-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCN)C(SC=3C(=CC=4C=COC=4C=3)I)=NC2=C1N BACXBYWHORYCAF-UHFFFAOYSA-N 0.000 description 1
- FGHXODPFIQASKW-UHFFFAOYSA-N 9-(3-aminopropyl)-8-[(6-iodo-1-benzofuran-5-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCN)C(SC=3C(=CC=4OC=CC=4C=3)I)=NC2=C1N FGHXODPFIQASKW-UHFFFAOYSA-N 0.000 description 1
- ZSKLUCJWRDEVER-UHFFFAOYSA-N 9-(3-aminopropyl)-8-[(6-iodo-2,3-dihydro-1h-indol-5-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCN)C(SC=3C(=CC=4NCCC=4C=3)I)=NC2=C1N ZSKLUCJWRDEVER-UHFFFAOYSA-N 0.000 description 1
- PGHGYYKIVAHEBB-UHFFFAOYSA-N 9-(3-aminopropyl)-8-[5-methoxy-2-(5-methylfuran-2-yl)phenyl]sulfanylpurin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCN)C=1SC1=CC(OC)=CC=C1C1=CC=C(C)O1 PGHGYYKIVAHEBB-UHFFFAOYSA-N 0.000 description 1
- QYJDQMHSZJKJSM-UHFFFAOYSA-N 9-(3-aminopropyl)-8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1h-inden-5-yl]sulfanyl]purin-6-amine Chemical compound O1C(C)=CN=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCCN)=CC2=C1CCC2 QYJDQMHSZJKJSM-UHFFFAOYSA-N 0.000 description 1
- SUSAUXQZMLMQGA-UHFFFAOYSA-N 9-(3-aminopropyl)-8-[[7-(5-methylfuran-2-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]purin-6-amine Chemical compound O1C(C)=CC=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCCN)=CC2=C1OCCO2 SUSAUXQZMLMQGA-UHFFFAOYSA-N 0.000 description 1
- FTGHFXMKOIQFOU-UHFFFAOYSA-N 9-(3-bromopropyl)-2-fluoro-8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)methyl]purin-6-amine Chemical compound N=1C=2C(N)=NC(F)=NC=2N(CCCBr)C=1CC(C(=C1)I)=CC2=C1CCO2 FTGHFXMKOIQFOU-UHFFFAOYSA-N 0.000 description 1
- QAVZGIJLJYXDOQ-UHFFFAOYSA-N 9-(3-bromopropyl)-8-(3-iodonaphthalen-2-yl)sulfanylpurin-6-amine Chemical compound C1=CC=C2C=C(I)C(SC=3N(CCCBr)C=4N=CN=C(C=4N=3)N)=CC2=C1 QAVZGIJLJYXDOQ-UHFFFAOYSA-N 0.000 description 1
- SYNIUTMQOGFIOZ-UHFFFAOYSA-N 9-(3-bromopropyl)-8-[(6-iodo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]purin-6-amine Chemical compound O1CCOC(C=C2I)=C1C=C2SC(N1CCCBr)=NC2=C1N=CN=C2N SYNIUTMQOGFIOZ-UHFFFAOYSA-N 0.000 description 1
- RMIANEPUQOPXQF-UHFFFAOYSA-N 9-(3-bromopropyl)-8-[(6-iodo-2,3-dihydro-1-benzofuran-5-yl)sulfanyl]purin-6-amine Chemical compound N=1C=2C(N)=NC=NC=2N(CCCBr)C=1SC(C(=C1)I)=CC2=C1OCC2 RMIANEPUQOPXQF-UHFFFAOYSA-N 0.000 description 1
- OEOBTHBDOCZSQX-UHFFFAOYSA-N 9-(3-bromopropyl)-8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)sulfanyl]purin-6-amine Chemical compound N=1C=2C(N)=NC=NC=2N(CCCBr)C=1SC(C(=C1)I)=CC2=C1CCC2 OEOBTHBDOCZSQX-UHFFFAOYSA-N 0.000 description 1
- MTVGSEGTXGSRHT-UHFFFAOYSA-N 9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-8-[3-(5-methyl-1,3-thiazol-2-yl)naphthalen-2-yl]sulfanylpurin-6-amine Chemical compound Cc1cnc(s1)-c1cc2ccccc2cc1Sc1nc2c(N)ncnc2n1CCC1CCCN(C1)S(C)(=O)=O MTVGSEGTXGSRHT-UHFFFAOYSA-N 0.000 description 1
- OIYMCHZGLOFSKR-UHFFFAOYSA-N 9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-8-[[3-(5-methyl-1,3-thiazol-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]sulfanyl]purin-6-amine Chemical compound CS(=O)(=O)N1CC(CCC1)CCN1C2=NC=NC(=C2N=C1SC1=CC=2CCCCC=2C=C1C=1SC(=CN=1)C)N OIYMCHZGLOFSKR-UHFFFAOYSA-N 0.000 description 1
- XDZYMLXLMPMIDK-UHFFFAOYSA-N 9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-8-[[5-(1H-pyrazol-5-yl)-2,3-dihydro-1H-indol-6-yl]sulfanyl]purin-6-amine Chemical compound CS(=O)(=O)N1CCCC(CCn2c(Sc3cc4NCCc4cc3-c3cc[nH]n3)nc3c(N)ncnc23)C1 XDZYMLXLMPMIDK-UHFFFAOYSA-N 0.000 description 1
- IEYDHPNTDZXKPC-UHFFFAOYSA-N 9-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-8-[[7-(propan-2-ylamino)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]purin-6-amine Chemical compound C(C)(C)NC=1C(=CC2=C(OCCO2)C=1)SC=1N(C2=NC=NC(=C2N=1)N)CCC1CN(CCC1)S(=O)(=O)C IEYDHPNTDZXKPC-UHFFFAOYSA-N 0.000 description 1
- DIBMXFJVQGNKAJ-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-2-fluoro-8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)methyl]purin-6-amine Chemical compound N1=C(F)N=C2N(CCNCC(C)(C)C)C(CC=3C(=CC=4CCOC=4C=3)I)=NC2=C1N DIBMXFJVQGNKAJ-UHFFFAOYSA-N 0.000 description 1
- UMYVCGUOGVLPMM-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-2-fluoro-8-[[6-(furan-2-yl)-1h-indol-5-yl]methyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCNCC(C)(C)C)C=1CC1=CC=2C=CNC=2C=C1C1=CC=CO1 UMYVCGUOGVLPMM-UHFFFAOYSA-N 0.000 description 1
- IIBJEKOJGQUWKB-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[(3-iodo-5,6,7,8-tetrahydronaphthalen-2-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)(C)C)C(SC=3C(=CC=4CCCCC=4C=3)I)=NC2=C1N IIBJEKOJGQUWKB-UHFFFAOYSA-N 0.000 description 1
- YVMQDVQLTUCVFQ-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[(5-iodo-2,3-dihydro-1-benzofuran-6-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)(C)C)C(SC=3C(=CC=4CCOC=4C=3)I)=NC2=C1N YVMQDVQLTUCVFQ-UHFFFAOYSA-N 0.000 description 1
- UODSJUKFKYVCTI-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[(6-iodo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)(C)C)C(SC=3C(=CC=4OCCOC=4C=3)I)=NC2=C1N UODSJUKFKYVCTI-UHFFFAOYSA-N 0.000 description 1
- HIHAAXIARJFGSG-UHFFFAOYSA-N 9-[2-(2,2-dimethylpropylamino)ethyl]-8-[(6-iodo-2,3-dihydro-1h-inden-5-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCNCC(C)(C)C)C(SC=3C(=CC=4CCCC=4C=3)I)=NC2=C1N HIHAAXIARJFGSG-UHFFFAOYSA-N 0.000 description 1
- YLAMCXRJROOFCK-UHFFFAOYSA-N 9-[2-(2-methylpropylamino)ethyl]-8-[(5-thiophen-2-yl-2,3-dihydro-1-benzofuran-6-yl)sulfanyl]purin-6-amine Chemical compound C(C(C)C)NCCN1C2=NC=NC(=C2N=C1SC1=CC2=C(CCO2)C=C1C=1SC=CC=1)N YLAMCXRJROOFCK-UHFFFAOYSA-N 0.000 description 1
- VKHZTFIFPAGOKL-UHFFFAOYSA-N 9-[2-(2-methylpropylamino)ethyl]-8-[(7-pyrrolidin-1-yl-2,3-dihydro-1,4-benzodioxin-6-yl)sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)C)C=1SC1=CC=2OCCOC=2C=C1N1CCCC1 VKHZTFIFPAGOKL-UHFFFAOYSA-N 0.000 description 1
- MZKZZZFJSYPWTP-UHFFFAOYSA-N 9-[2-(2-methylpropylamino)ethyl]-8-[[5-(1h-pyrazol-5-yl)-2,3-dihydro-1-benzofuran-6-yl]sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)C)C=1SC1=CC=2OCCC=2C=C1C1=CC=NN1 MZKZZZFJSYPWTP-UHFFFAOYSA-N 0.000 description 1
- FBDWMAIBQGTLJK-UHFFFAOYSA-N 9-[2-(2-methylpropylamino)ethyl]-8-[[5-(1h-pyrazol-5-yl)-2,3-dihydro-1-benzothiophen-6-yl]sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCNCC(C)C)C=1SC1=CC=2SCCC=2C=C1C1=CC=NN1 FBDWMAIBQGTLJK-UHFFFAOYSA-N 0.000 description 1
- YQORFHKVEAVTDF-UHFFFAOYSA-N 9-[3-(propan-2-ylamino)propyl]-8-[3-(1H-pyrazol-5-yl)naphthalen-2-yl]sulfanylpurin-6-amine Chemical compound CC(C)NCCCn1c(Sc2cc3ccccc3cc2-c2cc[nH]n2)nc2c(N)ncnc12 YQORFHKVEAVTDF-UHFFFAOYSA-N 0.000 description 1
- ULLRAZAROTVMGA-UHFFFAOYSA-N 9-[3-(propan-2-ylamino)propyl]-8-[[5-(1h-pyrazol-5-yl)-1h-indol-6-yl]sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)C)C=1SC1=CC=2NC=CC=2C=C1C1=CC=NN1 ULLRAZAROTVMGA-UHFFFAOYSA-N 0.000 description 1
- DCRJMRMEJAAGQM-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-2-fluoro-8-[[6-(1,3-oxazol-2-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-6-amine Chemical compound N=1C2=C(N)N=C(F)N=C2N(CCCNC(C)(C)C)C=1CC1=CC=2OCCOC=2C=C1C1=NC=CO1 DCRJMRMEJAAGQM-UHFFFAOYSA-N 0.000 description 1
- BABUTETYSPYIFM-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-2-fluoro-8-[[6-(4-methyl-1,3-thiazol-2-yl)-2,3-dihydro-1h-inden-5-yl]methyl]purin-6-amine Chemical compound CC1=CSC(C=2C(=CC=3CCCC=3C=2)CC=2N(C3=NC(F)=NC(N)=C3N=2)CCCNC(C)(C)C)=N1 BABUTETYSPYIFM-UHFFFAOYSA-N 0.000 description 1
- QDLDYNRHGYEMER-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-2-fluoro-8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1,4-benzodioxin-7-yl]methyl]purin-6-amine Chemical compound O1C(C)=CN=C1C(C(=C1)CC=2N(C3=NC(F)=NC(N)=C3N=2)CCCNC(C)(C)C)=CC2=C1OCCO2 QDLDYNRHGYEMER-UHFFFAOYSA-N 0.000 description 1
- GUACVABMNQGULP-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[(5-ethynyl-2,3-dihydro-1-benzofuran-6-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)(C)C)C(SC=3C(=CC=4CCOC=4C=3)C#C)=NC2=C1N GUACVABMNQGULP-UHFFFAOYSA-N 0.000 description 1
- CEDJPNVSLCCROV-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[(6-ethynyl-1-benzofuran-5-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)(C)C)C(SC=3C(=CC=4OC=CC=4C=3)C#C)=NC2=C1N CEDJPNVSLCCROV-UHFFFAOYSA-N 0.000 description 1
- BJLHSPSEFPRGOB-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[(6-ethynyl-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]-2-fluoropurin-6-amine Chemical compound N1=C(F)N=C2N(CCCNC(C)(C)C)C(CC=3C(=CC=4OCCOC=4C=3)C#C)=NC2=C1N BJLHSPSEFPRGOB-UHFFFAOYSA-N 0.000 description 1
- HTKMVETXQLTXOD-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[(6-ethynyl-4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)(C)C)C(SC=3C=C4OCCN(C4=CC=3C#C)C)=NC2=C1N HTKMVETXQLTXOD-UHFFFAOYSA-N 0.000 description 1
- WCEKUKMBCPOEPZ-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[(6-iodo-3,4-dihydro-2h-chromen-7-yl)sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)(C)C)C(SC=3C(=CC=4CCCOC=4C=3)I)=NC2=C1N WCEKUKMBCPOEPZ-UHFFFAOYSA-N 0.000 description 1
- YEXOWVMUERSDKU-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[(7-cyclopropyl-2,3-dihydro-1,4-benzodioxin-6-yl)sulfanyl]purin-6-amine Chemical compound CC(C)(C)NCCCn1c(Sc2cc3OCCOc3cc2C2CC2)nc2c(N)ncnc12 YEXOWVMUERSDKU-UHFFFAOYSA-N 0.000 description 1
- NXUMAGWWQLDDAR-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[5-(1,3-oxazol-2-yl)-2,3-dihydro-1-benzofuran-6-yl]sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)(C)C)C=1SC1=CC=2OCCC=2C=C1C1=NC=CO1 NXUMAGWWQLDDAR-UHFFFAOYSA-N 0.000 description 1
- JCTBHJDXYVQMND-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[5-(1,3-thiazol-2-yl)-2,3-dihydro-1-benzofuran-6-yl]sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)(C)C)C=1SC1=CC=2OCCC=2C=C1C1=NC=CS1 JCTBHJDXYVQMND-UHFFFAOYSA-N 0.000 description 1
- UIQJHLGIRXLKIY-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[5-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1-benzofuran-6-yl]sulfanyl]purin-6-amine Chemical compound O1C(C)=CN=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCCNC(C)(C)C)=CC2=C1OCC2 UIQJHLGIRXLKIY-UHFFFAOYSA-N 0.000 description 1
- UTQZMRYLJVEVHM-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[5-(5-methyl-1,3-thiazol-2-yl)-2,3-dihydro-1-benzofuran-6-yl]sulfanyl]purin-6-amine Chemical compound S1C(C)=CN=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCCNC(C)(C)C)=CC2=C1OCC2 UTQZMRYLJVEVHM-UHFFFAOYSA-N 0.000 description 1
- GXNBUVINYQGGHB-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[5-(dimethylamino)-1-benzofuran-6-yl]sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)(C)C)C(SC3=CC=4OC=CC=4C=C3N(C)C)=NC2=C1N GXNBUVINYQGGHB-UHFFFAOYSA-N 0.000 description 1
- WYVFSHHPVMHLRC-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[6-(1,3-thiazol-2-yl)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]purin-6-amine Chemical compound N=1C2=C(N)N=CN=C2N(CCCNC(C)(C)C)C=1SC1=CC=2CCOC=2C=C1C1=NC=CS1 WYVFSHHPVMHLRC-UHFFFAOYSA-N 0.000 description 1
- JUDWGZHYSWBFCR-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[6-(4-methyl-1,3-thiazol-2-yl)-2,3-dihydro-1h-inden-5-yl]sulfanyl]purin-6-amine Chemical compound CC1=CSC(C=2C(=CC=3CCCC=3C=2)SC=2N(C3=NC=NC(N)=C3N=2)CCCNC(C)(C)C)=N1 JUDWGZHYSWBFCR-UHFFFAOYSA-N 0.000 description 1
- WNOCIAXTBJNJJP-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]purin-6-amine Chemical compound O1C(C)=CN=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCCNC(C)(C)C)=CC2=C1CCO2 WNOCIAXTBJNJJP-UHFFFAOYSA-N 0.000 description 1
- ADNHXKAJNVTEMB-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[6-(5-methyl-1,3-oxazol-2-yl)-2,3-dihydro-1h-inden-5-yl]sulfanyl]purin-6-amine Chemical compound O1C(C)=CN=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCCNC(C)(C)C)=CC2=C1CCC2 ADNHXKAJNVTEMB-UHFFFAOYSA-N 0.000 description 1
- PHRAWFATGOOKBQ-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[6-(5-methyl-1,3-thiazol-2-yl)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]purin-6-amine Chemical compound S1C(C)=CN=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCCNC(C)(C)C)=CC2=C1CCO2 PHRAWFATGOOKBQ-UHFFFAOYSA-N 0.000 description 1
- OFKSCCKHJQADFE-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[6-(5-methylfuran-2-yl)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]purin-6-amine Chemical compound C(C)(C)(C)NCCCN1C2=NC=NC(=C2N=C1SC=1C(=CC2=C(CCO2)C=1)C=1OC(=CC=1)C)N OFKSCCKHJQADFE-UHFFFAOYSA-N 0.000 description 1
- WXUJAHPGDHQPFL-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[6-(dimethylamino)-1-benzofuran-5-yl]sulfanyl]purin-6-amine Chemical compound C(C)(C)(C)NCCCN1C2=NC=NC(=C2N=C1SC=1C(=CC2=C(C=CO2)C1)N(C)C)N WXUJAHPGDHQPFL-UHFFFAOYSA-N 0.000 description 1
- CHFJGWUKTLJFQG-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[6-(dimethylamino)-2,3-dihydro-1-benzofuran-5-yl]sulfanyl]purin-6-amine Chemical compound N1=CN=C2N(CCCNC(C)(C)C)C(SC3=CC=4CCOC=4C=C3N(C)C)=NC2=C1N CHFJGWUKTLJFQG-UHFFFAOYSA-N 0.000 description 1
- IRJKCOGYDDNCRW-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[7-(5-methylfuran-2-yl)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]purin-6-amine Chemical compound O1C(C)=CC=C1C(C(=C1)SC=2N(C3=NC=NC(N)=C3N=2)CCCNC(C)(C)C)=CC2=C1OCCO2 IRJKCOGYDDNCRW-UHFFFAOYSA-N 0.000 description 1
- FKILFXAEKYYQAX-UHFFFAOYSA-N 9-[3-(tert-butylamino)propyl]-8-[[7-(dimethylamino)-2,3-dihydro-1,4-benzodioxin-6-yl]sulfanyl]purin-6-amine Chemical compound CN(C)c1cc2OCCOc2cc1Sc1nc2c(N)ncnc2n1CCCNC(C)(C)C FKILFXAEKYYQAX-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 206010015548 Euthanasia Diseases 0.000 description 1
- HNYVDIURSBJSAG-UHFFFAOYSA-N FC1=NC(=C2N=CN(C2=N1)CCNCC(C)(C)C)N Chemical compound FC1=NC(=C2N=CN(C2=N1)CCNCC(C)(C)C)N HNYVDIURSBJSAG-UHFFFAOYSA-N 0.000 description 1
- 101000711796 Homo sapiens Sclerostin Proteins 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910013470 LiC1 Inorganic materials 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 208000009905 Neurofibromatoses Diseases 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102100034201 Sclerostin Human genes 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 102100036980 Talin-2 Human genes 0.000 description 1
- 101710142305 Talin-2 Proteins 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- AHWZCYVXODSVGD-UHFFFAOYSA-N [2,3-bis(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(F)(F)F)=C1C(F)(F)F AHWZCYVXODSVGD-UHFFFAOYSA-N 0.000 description 1
- BPTABBGLHGBJQR-UHFFFAOYSA-N [3,5-bis(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 BPTABBGLHGBJQR-UHFFFAOYSA-N 0.000 description 1
- RIIPFHVHLXPMHQ-UHFFFAOYSA-N [4-(dimethylamino)phenyl]boronic acid Chemical compound CN(C)C1=CC=C(B(O)O)C=C1 RIIPFHVHLXPMHQ-UHFFFAOYSA-N 0.000 description 1
- XAXXTYXMWOFKLW-UHFFFAOYSA-N [C-]1=CC=[NH+]1 Chemical compound [C-]1=CC=[NH+]1 XAXXTYXMWOFKLW-UHFFFAOYSA-N 0.000 description 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical class C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000006323 alkenyl amino group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 229940098164 augmentin Drugs 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- BQXQGZPYHWWCEB-UHFFFAOYSA-N carazolol Chemical compound N1C2=CC=CC=C2C2=C1C=CC=C2OCC(O)CNC(C)C BQXQGZPYHWWCEB-UHFFFAOYSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- NSQBADKMIYCCSC-UHFFFAOYSA-N ethyl 2-(3-hydroxyphenyl)acetate Chemical compound CCOC(=O)CC1=CC=CC(O)=C1 NSQBADKMIYCCSC-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 150000002545 isoxazoles Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 201000004931 neurofibromatosis Diseases 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- QDTOWROMMFMKDC-UHFFFAOYSA-N oxadiazole-5-carbonitrile Chemical compound N#CC1=CN=NO1 QDTOWROMMFMKDC-UHFFFAOYSA-N 0.000 description 1
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- ICFQGMYPBURXAZ-UHFFFAOYSA-N pentane-1-sulfonamide Chemical compound CCCCCS(N)(=O)=O ICFQGMYPBURXAZ-UHFFFAOYSA-N 0.000 description 1
- 125000004894 pentylamino group Chemical group C(CCCC)N* 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000004545 purin-9-yl group Chemical group N1=CN=C2N(C=NC2=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- WOGMLDNCNBLDCA-JSYANWSFSA-M sodium;(2r,3z,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound [Na+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 WOGMLDNCNBLDCA-JSYANWSFSA-M 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- DCVICHWBECIALB-UHFFFAOYSA-N tert-butyl 2,3-dihydropyrrole-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC=C1 DCVICHWBECIALB-UHFFFAOYSA-N 0.000 description 1
- AZFIXUGFEFRFQJ-UHFFFAOYSA-N tert-butyl n-naphthalen-2-ylcarbamate Chemical compound C1=CC=CC2=CC(NC(=O)OC(C)(C)C)=CC=C21 AZFIXUGFEFRFQJ-UHFFFAOYSA-N 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- XSROQCDVUIHRSI-UHFFFAOYSA-N thietane Chemical compound C1CSC1 XSROQCDVUIHRSI-UHFFFAOYSA-N 0.000 description 1
- 125000004001 thioalkyl group Chemical group 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24934909P | 2009-10-07 | 2009-10-07 | |
| PCT/US2010/051872 WO2011044394A1 (en) | 2009-10-07 | 2010-10-07 | Purine derivatives useful as hsp90 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201270535A1 EA201270535A1 (ru) | 2012-09-28 |
| EA029272B1 true EA029272B1 (ru) | 2018-03-30 |
Family
ID=43857159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201270535A EA029272B1 (ru) | 2009-10-07 | 2010-10-07 | Пуриновые производные, применимые в качестве ингибиторов hsp90 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9328114B2 (https=) |
| EP (2) | EP3091019B1 (https=) |
| JP (3) | JP5941407B2 (https=) |
| KR (2) | KR101906568B1 (https=) |
| CN (3) | CN106083855B (https=) |
| AU (1) | AU2010303343B2 (https=) |
| BR (1) | BR112012008019A2 (https=) |
| CA (1) | CA2776308C (https=) |
| DK (1) | DK2486039T3 (https=) |
| EA (1) | EA029272B1 (https=) |
| ES (2) | ES2733131T3 (https=) |
| LT (1) | LT2486039T (https=) |
| MX (1) | MX340714B (https=) |
| NZ (2) | NZ599138A (https=) |
| PT (1) | PT2486039T (https=) |
| WO (1) | WO2011044394A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9403828B2 (en) | 2005-02-01 | 2016-08-02 | Sloan-Kettering Institute For Cancer Research | Small-molecule Hsp90 inhibitors |
| US7834181B2 (en) | 2005-02-01 | 2010-11-16 | Slaon-Kettering Institute For Cancer Research | Small-molecule Hsp90 inhibitors |
| WO2008005937A2 (en) | 2006-06-30 | 2008-01-10 | Sloan-Kettering Institute For Cancer Research | Treatment of neurodegenerative diseases through inhibiton of hsp90 |
| JP5941407B2 (ja) | 2009-10-07 | 2016-06-29 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Hsp90阻害剤 |
| CN103596955B (zh) | 2011-04-05 | 2016-11-16 | 索隆-基特林癌症研究协会 | Hsp90抑制剂 |
| JP6266506B2 (ja) | 2011-04-05 | 2018-01-24 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Hsp90阻害物質 |
| EA201490230A1 (ru) * | 2011-07-08 | 2014-06-30 | Слоан-Кеттеринг Инститьют Фор Кэнсер Рисерч | Применение меченых ингибиторов hsp90 |
| EP2972394A4 (en) | 2013-03-15 | 2016-11-02 | Sloan Kettering Inst Cancer | HSP90-DESIGNING AND THERAPY |
| SG11201601542SA (en) | 2013-08-16 | 2016-04-28 | Sloan Kettering Inst Cancer | Selective grp94 inhibitors and uses thereof |
| BR112016005199B1 (pt) | 2013-08-23 | 2022-02-22 | Neupharma, Inc | Certos compostos químicos, composições, e métodos |
| WO2015138039A1 (en) | 2013-12-23 | 2015-09-17 | Memorial Sloan-Kettering Cancer Center | Methods and reagents for radiolabeling |
| MX387627B (es) * | 2014-09-17 | 2025-03-18 | Memorial Sloan Kettering Cancer Center | Formación de imágenes de inflamación e infección dirigida a hsp90 y terapia |
| US20180280397A1 (en) | 2015-10-05 | 2018-10-04 | Memorial Sloan Kettering Cancer Center | Rational combination therapy for the treatment of cancer |
| WO2018035061A1 (en) | 2016-08-15 | 2018-02-22 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| KR20190138871A (ko) * | 2017-04-24 | 2019-12-16 | 사무스 테라퓨틱스, 인코포레이티드 | Hsp90 저해제 경구 제형 및 관련 방법 |
| CN111683658A (zh) * | 2017-06-23 | 2020-09-18 | 萨缪斯治疗股份有限公司 | 用于创伤性脑损伤及其后遗症的多蛋白复合物抑制剂疗法 |
| TW202508595A (zh) | 2023-05-04 | 2025-03-01 | 美商銳新醫藥公司 | 用於ras相關疾病或病症之組合療法 |
| US20250049810A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025099111A1 (en) | 2023-11-10 | 2025-05-15 | Wella Germany Gmbh | New telescoping syntheses of 6-hydroxy-benzomorpholine (3,4-dihydro-2h-1,4-benzoxazin-6-ol) |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| TW202547461A (zh) | 2024-05-17 | 2025-12-16 | 美商銳新醫藥公司 | Ras抑制劑 |
| WO2025255438A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003037860A2 (en) * | 2001-10-30 | 2003-05-08 | Conforma Therapeutics Corporation | Purine analogs having hsp90-inhibiting activity |
| WO2006084030A2 (en) * | 2005-02-01 | 2006-08-10 | Sloan-Kettering Institute For Cancer Research | Small-molecule hsp90 inhibitors |
| WO2007134298A2 (en) * | 2006-05-12 | 2007-11-22 | Myriad Genetics, Inc. | Therapeutic compounds and their use in cancer |
| WO2008115719A1 (en) * | 2007-03-20 | 2008-09-25 | Curis, Inc. | Fused amino pyridine as hsp90 inhibitors |
| WO2009007399A1 (en) * | 2007-07-12 | 2009-01-15 | Crystax Pharmaceuticals, S.L. | New compounds as hsp90 inhibitors |
| WO2009065035A1 (en) * | 2007-11-14 | 2009-05-22 | Myriad Genetics, Inc. | Therapeutic compounds and their use in treating diseases and disorders |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2287387C (en) | 1997-05-14 | 2010-02-16 | Sloan-Kettering Institute For Cancer Research | Methods and compositions for destruction of selected proteins |
| JP2002541255A (ja) | 1999-04-09 | 2002-12-03 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Her族チロシンキナーゼの分解および/または阻害方法および組成物 |
| US7439359B2 (en) | 2000-11-02 | 2008-10-21 | Sloan-Kettering Institute For Cancer Research | Small molecule compositions for binding to hsp90 |
| NL1019258C2 (nl) * | 2001-10-30 | 2003-05-02 | Iku Holding Montfoort Bv | Bevestigingsconstructie, in het bijzonder voor een buitenspiegel van een motorvoertuig. |
| EP1450784A4 (en) | 2001-11-09 | 2005-02-09 | Conforma Therapeutics Corp | HSP90-INHIBITABLE ZEARALANOL COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE |
| CN1649866A (zh) | 2002-02-28 | 2005-08-03 | 阿斯特拉曾尼卡有限公司 | 3-环状基-5-(含氮5-元环)甲基-噁唑烷酮衍生物及其作为抗菌药物的用途 |
| EP1620564A4 (en) | 2003-04-18 | 2008-03-12 | Cytovia Inc | METHOD FOR TREATING DISEASES RESPONSING TO APOPTOSIS INDUCTION AND SCREENING TESTS |
| MXPA06002997A (es) | 2003-09-18 | 2007-02-08 | Conforma Therapeutics Corp | Novedosos compuestos heterociclicos como inhibidores- hsp90. |
| US9403828B2 (en) | 2005-02-01 | 2016-08-02 | Sloan-Kettering Institute For Cancer Research | Small-molecule Hsp90 inhibitors |
| EP1913738A2 (en) | 2005-07-27 | 2008-04-23 | QUALCOMM Incorporated | System and method for forward link only messages |
| WO2007143629A1 (en) | 2006-06-02 | 2007-12-13 | Nexgenix Pharmaceuticals | Treatment of neurofibromatosis with inhibitors of a signal transduction pathway |
| US20080053862A1 (en) | 2006-06-30 | 2008-03-06 | Sanford, L.P. | Interlocking Nestable Article Holder |
| WO2008005937A2 (en) | 2006-06-30 | 2008-01-10 | Sloan-Kettering Institute For Cancer Research | Treatment of neurodegenerative diseases through inhibiton of hsp90 |
| CL2007002994A1 (es) * | 2006-10-19 | 2008-02-08 | Wyeth Corp | Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros. |
| WO2008115262A2 (en) | 2007-03-20 | 2008-09-25 | Curis, Inc. | Hsp90 inhibitors containing a zinc binding moiety |
| WO2009042646A1 (en) | 2007-09-24 | 2009-04-02 | Curis, Inc. | Anti-proliferative agents |
| JP5941407B2 (ja) | 2009-10-07 | 2016-06-29 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Hsp90阻害剤 |
| CN103596955B (zh) | 2011-04-05 | 2016-11-16 | 索隆-基特林癌症研究协会 | Hsp90抑制剂 |
| JP6266506B2 (ja) | 2011-04-05 | 2018-01-24 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Hsp90阻害物質 |
| SG11201601542SA (en) | 2013-08-16 | 2016-04-28 | Sloan Kettering Inst Cancer | Selective grp94 inhibitors and uses thereof |
-
2010
- 2010-10-07 JP JP2012533327A patent/JP5941407B2/ja not_active Expired - Fee Related
- 2010-10-07 EP EP16171952.1A patent/EP3091019B1/en not_active Not-in-force
- 2010-10-07 AU AU2010303343A patent/AU2010303343B2/en not_active Ceased
- 2010-10-07 NZ NZ599138A patent/NZ599138A/en not_active IP Right Cessation
- 2010-10-07 BR BR112012008019A patent/BR112012008019A2/pt not_active IP Right Cessation
- 2010-10-07 NZ NZ625593A patent/NZ625593A/en not_active IP Right Cessation
- 2010-10-07 CA CA2776308A patent/CA2776308C/en not_active Expired - Fee Related
- 2010-10-07 LT LTEP10822718.2T patent/LT2486039T/lt unknown
- 2010-10-07 US US13/500,809 patent/US9328114B2/en active Active
- 2010-10-07 CN CN201610269904.3A patent/CN106083855B/zh not_active Expired - Fee Related
- 2010-10-07 KR KR1020127011546A patent/KR101906568B1/ko not_active Expired - Fee Related
- 2010-10-07 WO PCT/US2010/051872 patent/WO2011044394A1/en not_active Ceased
- 2010-10-07 EA EA201270535A patent/EA029272B1/ru not_active IP Right Cessation
- 2010-10-07 CN CN201610270112.8A patent/CN105924443A/zh active Pending
- 2010-10-07 ES ES16171952T patent/ES2733131T3/es active Active
- 2010-10-07 PT PT108227182T patent/PT2486039T/pt unknown
- 2010-10-07 MX MX2012004089A patent/MX340714B/es active IP Right Grant
- 2010-10-07 EP EP10822718.2A patent/EP2486039B1/en active Active
- 2010-10-07 DK DK10822718.2T patent/DK2486039T3/en active
- 2010-10-07 CN CN201080055473.1A patent/CN102639534A/zh active Pending
- 2010-10-07 KR KR1020187028594A patent/KR102129420B1/ko not_active Expired - Fee Related
- 2010-10-07 ES ES10822718.2T patent/ES2589403T3/es active Active
-
2016
- 2016-04-21 US US15/135,121 patent/US10172863B2/en active Active
- 2016-05-20 JP JP2016101964A patent/JP6326088B2/ja not_active Expired - Fee Related
-
2018
- 2018-02-15 JP JP2018024710A patent/JP6804483B2/ja not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003037860A2 (en) * | 2001-10-30 | 2003-05-08 | Conforma Therapeutics Corporation | Purine analogs having hsp90-inhibiting activity |
| WO2006084030A2 (en) * | 2005-02-01 | 2006-08-10 | Sloan-Kettering Institute For Cancer Research | Small-molecule hsp90 inhibitors |
| WO2007134298A2 (en) * | 2006-05-12 | 2007-11-22 | Myriad Genetics, Inc. | Therapeutic compounds and their use in cancer |
| WO2008115719A1 (en) * | 2007-03-20 | 2008-09-25 | Curis, Inc. | Fused amino pyridine as hsp90 inhibitors |
| WO2009007399A1 (en) * | 2007-07-12 | 2009-01-15 | Crystax Pharmaceuticals, S.L. | New compounds as hsp90 inhibitors |
| WO2009065035A1 (en) * | 2007-11-14 | 2009-05-22 | Myriad Genetics, Inc. | Therapeutic compounds and their use in treating diseases and disorders |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA029272B1 (ru) | Пуриновые производные, применимые в качестве ингибиторов hsp90 | |
| KR102227629B1 (ko) | 치환된 잔틴 및 그것의 사용 방법 | |
| BG107959A (bg) | Заместени производни на триазол диамин като киназни инхибитори | |
| JP6442005B2 (ja) | ベンゾオキサゼピン化合物の作製方法 | |
| AU2020299592A1 (en) | Heterocyclic compounds as BET inhibitors | |
| CA3110576A1 (en) | Compounds for treating certain leukemias | |
| CN104220437B (zh) | α2肾上腺素受体激动剂 | |
| WO2003106455A1 (en) | Azole methylidene cyanide derivatives and their use as protein kinase modulators | |
| AU2013204109B2 (en) | Purine derivatives useful as hsp90 inhibitors | |
| EA050841B1 (ru) | Гетероциклические производные для лечения расстройств, опосредованных trpm3 | |
| HK1230612A (en) | Purine derivatives useful as hsp90 inhibitors | |
| HK1230612A1 (en) | Purine derivatives useful as hsp90 inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |